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ABSTRACT 
The importance of maintaining maternal wellbeing during the antenatal period is 
mandatory to the mother and the baby. Although asymptomatic maternal tachycardia 
could be seen as part of the physiological changes during pregnancy, it could also be 
a sign of a serious underlying condition. Previous studies have shown that maternal 
deaths could occur in women with pre-existing cardiac conditions (Naidoo, Desai & 
Moodley, 2002:17). The concern that many conditions associated with maternal 
tachycardia pass through the health care system without being noticed or investigated 
motivated the researcher to undertake this study. 
The study aimed to determine the prevalence of maternal tachycardia during late 
pregnancy and its association with anaemia, major cardiac diseases and/or 
complications and adverse maternal and perinatal outcomes. A case-control 
retrospective study design within a prospective study was employed with a 
quantitative approach. A total sample size of 204 participants, constituting 14.3% of 
the study population (N=1431) was purposefully selected from the Monica AN24™ 
recordings of the Safe Passage Study at Tygerberg Hospital to collect the data. 
Ethical approval was obtained from the Health Research Ethics Committee of the 
Faculty of Medicine and Health Sciences, Stellenbosch University and a waiver of 
consent had been granted.  
A group of 16 participants, who met the inclusion criteria, constituting 7.8% of the total 
sample, was selected for the pilot study. Reliability and validity was ensured by the 
pilot study and pre-testing the data collection instrument as it was tested under the 
exact circumstances as the actual study experts in the field of nursing and medical 
research and statistics were used. The data was analyzed by the use of the 
STATISTICA version 9 programme. 
The results show a 7.1% (n=102) prevalence of maternal tachycardia in late 
pregnancy. There were no pre-existing cardiac conditions in any of the groups and no 
maternal cardiac complications during pregnancy and delivery. The case group had a 
higher incidence (55.0%) of haemoglobin values lower than 11.0 g/dL than the control 
group (47.0%), however the Mann-Whitney U test revealed no statistically significant 
difference of the Hb values at 28 to 38 weeks between the case and the control 
groups. The participants presenting with anaemia (Hb < 11.0 g/dL) were classified as 
mild anaemia (Hb value of 7.0 – 10.9 g/dL). There were no participants that presented 
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with severe anaemia (Hb value of < 7.0g/dL). There was an increased prevalence 
(9.1%) of infection in the participants presenting with maternal tachycardia, although 
this difference was not significant between the two groups. The infant outcome 
revealed an increased mean birth weight of 194g for the case group that presented 
with maternal tachycardia. 
Several recommendations were identified that were grounded in the study findings. 
The findings reveal that the current antenatal care practice in terms of not recording 
the maternal heart rate is sufficient. 
Stellenbosch University  http://scholar.sun.ac.za
v 
 
OPSOMMING 
Die belangrikheid van die handhawing van moederlike welsyn gedurende die 
voorgeboorte tydperk is noodsaaklik vir die moeder en die baba. Alhoewel  
asimptomatiese moederlike tagikardie gesien kan word as deel van die fisiologiese 
veranderinge tydens swangerskap, kan dit ook 'n teken wees van 'n ernstige 
onderliggende toestand. Vorige studies het aangetoon dat moederlike sterftes kan 
voorkom in vroue met voorafgaande harttoestande (Naidoo, Desai & Moodley, 
2002:17). Die kommer dat verskeie toestande wat verband hou met moederlike 
tagikardie, deur die gesondheidsorg stelsel kan deurglip sonder om opgemerk te 
word, het die navorser gemotiveer om hierdie studie te onderneem. 
Die studie is daarop gemik om die voorkoms van moederlike tagikardie tydens laat 
swangerskap en sy verbintenis met anemie, ernstige hartsiektes en/of komplikasies 
en ongunstige moederlike en perinatale uitkoms te bepaal. 'n Gevalkontrole 
retrospektiewe studie-ontwerp binne 'n voornemende studie is gebruik met 'n 
kwantitatiewe benadering. 'n Totale steekproefgrootte van 204 deelnemers, wat 
14.3% van die populasie (N=1431) uitmaak is op ‘n doelgerigte manier uitgekies uit 
die Monica AN24™ opnames van die Veilige Geboorte Studie by Tygerberg Hospitaal 
om die data in te samel. Etiese goedkeuring is verkry van die Mensnavorsing Etiese 
komitee komitee van Fakulteit van Geneeskunde en Gesondheidswetenskappe van 
die Universiteit Stellenbosch en 'n kwytskelding van toestemming is verleen.  
'n Groep van 16 deelnemers, wat voldoen aan die insluitingskriteria, wat 7,8% van die 
totale steekproef bestaan, is geselekteer vir die loodsstudie. Betroubaarheid en 
geldigheid is verseker deur die loodsstudie en die voorafgaande toets van die data-
insamelingsinstrument onder presies dieselfde omstandighede as die werklike studie 
sowel as die gebruik van kenners in die gebied van verpleging en mediese navorsing 
en statistiek. Die data is ontleed deur die gebruik van die Statistica weergawe 9 
program. 
Die resultate toon 'n 7,1% (n=102) voorkoms van moederlike tagikardie in laat 
swangerskap. Daar was geen onderliggende harttoestande in enige van die groepe 
en geen moederlike hartkomplikasies tydens swangerskap en geboorte nie. Die 
gevalgroep het 'n hoër voorkoms (55,0%) van Hb waardes laer as 11.0 g/dl as die 
kontrole groep (47.0%) gehad, maar die Mann-Whitney U-toets toon geen statisties 
beduidende verskil in die Hb waardes by 28-38 weke tussen die geval en die 
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kontrolegroepe nie. Die deelnemers met anemie (Hb < 11.0 g/dl) is geklassifiseer met 
ligte bloedarmoede (Hb waarde van 7.0-10.9 g/dl). Daar was geen deelnemers wat 
erge bloedarmoede (Hb waarde van < 7.0g/dL) getoon het nie. Daar was verhoogde 
voorkoms (9,1%) van infeksie in die deelnemers met moederlike tagikardie, hoewel 
die verskil nie beduidend tussen die twee groepe was nie. Die baba uitkoms toon 'n 
toename in gemiddelde geboortegewig van 194g vir die gevalgroep wat met 
moederlike tagikardie gediagnoseer is. 
Verskeie aanbevelings is geïdentifiseer wat in die studie se bevindinge gegrond is. 
Die bevindinge dui daarop dat die huidige voorgeboortelike sorgpraktyk in terme van 
nie rekordering van die moederlike hartspoed voldoende is. 
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 called “cot death” and implies that a baby has been found dead for no 
 obvious reason (Black’s Medical Dictionary, 2010). 
Tachycardia:  Is defined as a rise in the heart rate above the normal range at rest 
between 60 and 100 beats per minute. It can sometimes be 
accompanied by irregularities in rhythm (arrhythmia) (Black’s medical 
dictionary, 2010).  
WHO:  World Health Organisation (Mosby's Dictionary of Medicine, Nursing, & 
Health Professions, 2009). 
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CHAPTER 1: SCIENTIFIC FOUNDATION FOR THE 
STUDY 
1.1 INTRODUCTION 
1.1.1 Background and preliminary review of relevant literature 
When pregnant women book at the antenatal clinic, their health information is 
recorded in a booklet, namely the maternity case record, or previously (before the 1st 
of October 2010), on a green antenatal card, which is then given to them after the first 
antenatal visit for their safekeeping. This booklet or antenatal card is presented with 
each subsequent antenatal visit and relevant information is then recorded by the 
health care provider. The purpose of the antenatal card/booklet is to summarise 
necessary information regarding the pregnancy in order for the health care provider to 
identify risk factors that could influence the course of the pregnancy and labour.  
As the mentioned antenatal card is designed in a way that only necessary information 
can be recorded, the risk of leaving out some relevant information could occur. A 
possible void is that there is no provision made to record the maternal heart rate on 
the antenatal card except for under the heading “notes”. This space for entries, 
however, is limited. The void is thus that no provision has been made to record the 
maternal heart rate on the antenatal card.  
The maternity case record however, is designed to enter all necessary obstetric 
information. The progress of a pregnancy and labour can be recorded from the first 
antenatal visit until the discharge after labour. There is no provision made for the 
routine monitoring of the maternal heart rate during the antenatal period unless the 
mother is admitted to hospital. By the recording of the maternal heart rate, possible 
problems may be identified early during pregnancy and gives one the opportunity to 
investigate the underlying cause and provide the adequate and necessary care.  
In a situation where state hospitals and clinics, as well as private health care facilities, 
become very busy dealing with an overflow of patients, the potential for problems in 
health care such as time management, and/or the decline in the standard of record-
keeping according to protocol, can arise. Although the lack of time could often result in 
doing only the necessary observations and diagnostic tests, this is not an appropriate 
professional excuse. Unfortunately it could happen that the health care provider will 
only provide the necessary care that is required from him/her, for example by 
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measuring the pregnant woman’s blood pressure, but could be reluctant in monitoring 
the respiration or heart rate. Alternatively the health care provider might do these 
observations, but not record it on the antenatal card/booklet or in the patient notes.  
Jefferies, Johnson and Griffiths (2010:113) maintain that clinical record-keeping plays 
an important role to all health care professionals including nurses, as it enables them 
to consider a far greater number of options when making a decision about the 
patient’s condition. The authors mention that it is often argued that a nursing task 
performed, but not documented, is assumed in a legal context that this task has not 
been performed and the patient has suffered neglect arising from a lack of care. 
However, it can also happen that the patients forget or lose these cards, which 
unfortunately leads to the loss of valuable information, as there are often no duplicate 
documents available at the hospitals or clinics.  
Gelson and Johnson (2010:617), remind us that the purpose of antenatal care is to 
ensure the continued wellbeing of the mother and fetus. The authors also highlight the 
importance of the prompt treatment of anaemia, urinary tract infection and 
arrhythmias. Intervention before major cardiac decompensation and the early 
diagnosis and management of conditions such as pre-eclampsia can prevent 
significant problems. Furthermore, the occurrence of cardiac symptoms, such as 
palpitations, chest pain and severe shortness of breath, should prompt early referral 
for investigation, promoting the timely diagnosis of an unsuspected cardiac disease in 
pregnant women. Therefore the researcher supported this authors’ opinion that it is 
relevant to acknowledge the importance of the documentation of symptoms and 
findings during an antenatal consultation. 
A Cochrane library search and Statistics SA search with the keywords “tachycardia”; 
“maternal tachycardia”; “nursing documentation of maternal tachycardia”; “prevalence 
of maternal tachycardia”; and “importance of nursing documentation of maternal 
tachycardia” revealed limited results for the time span 2006 to present, of which no 
review or study was related to the researcher’s topic of interest. The majority of 
articles regarding tachycardia that were reviewed had been linked to a reaction to 
medication, resulting in tachycardia. However, no results were found regarding 
tachycardia being acted on or not, for the time span 2006 to present.  
The Perinatal Education Programme (PEP) of the Western Cape (Woods, 2006, unit 
1:6), highlights the importance of measuring blood pressure and pulse rate during the 
examination of the respiratory and cardiovascular system. However, it does not 
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provide guidance on the routine monitoring and assessment of the maternal heart rate 
during the course of pregnancy. The researcher assumed that tachycardia is often not 
measured and recorded at the antenatal clinics as there is either inadequate 
emphasis on routine monitoring of the maternal heart rate, and/or no provision is 
made for the monitoring and recording thereof.  
According to Hanson (2010:9) maternal tachycardia could be a sign of a serious 
underlying condition, such as sepsis, and/or other potential intrapartum problems, 
such as anaemia (Woods, 2006, unit 13:5; Kotchetkov, Patel & Salehian, 2010:42). 
Lack of attention to maternal tachycardia during pregnancy could result in a potentially 
serious condition, such as maternal heart failure (Woods, 2006, unit 13:5). Therefore, 
the researcher was of the opinion that it is in the patient’s best interest to monitor the 
maternal heart rate on a regular basis during routine antenatal care as any untreated 
or overlooked sign or symptom could potentially exacerbate a condition during 
pregnancy.  
During pregnancy the pregnant woman’s body undergoes significant physiological 
changes. These changes include changes to various systems of the body namely, the 
skin; reproductive organs; cardiovascular, haematological, renal, musculoskeletal, 
neurological, gastrointestinal (Sammaritano, 2010:729); endocrine, immune, 
respiratory, and alimentary systems; as well as the general metabolism (Sellers, 
2004:141). Adapting to physiological changes can be both stressful and possibly life 
threatening in women with undiagnosed or undetected compromised cardiac function.   
According to Klein and Galan (2004:446) the normal physiological changes include an 
increase in heart rate by 10 to 20 beats per minute, whereas sinus tachycardia is 
defined as a heart rate of at least 100 beats per minute. This study also mentions that 
the presence of the latter in an asymptomatic woman is not uncommon and can often 
be of no pathologic origin. Stein, Hagley, Cole, Domitrovich, Kleiger and Rottman 
(1999:980) studied the changes in 24-hour heart rate variability during normal 
pregnancy and found that the mean heart rate in normal, non-pregnant women is 76 
beats per minute but increases to 87 beats per minute during pregnancy. Ferrero, 
Colombo and Ragni (2004:244) also mentioned that there is an increase in maternal 
cardiac arrhythmias during pregnancy. However, Tan (2010:113) states that cardiac 
arrhythmias are uncommon in pregnancy due to the low prevalence of heart disease 
in women in the reproductive age group. These findings are important, therefore the 
health care provider should not overlook either of them. 
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A study conducted in Sri Lanka by Haththotuwa, Attygalle, Jayatilleka, Karunaratna 
and Thorne (2009:197) investigated maternal deaths due to cardiac disease. The total 
number of maternal deaths that were reported was 145. There were 42 indirect deaths 
of which 25 were due to cardiac disease. This study considered interventions to 
reduce the maternal deaths. As part of their interventions, they suggested the early 
detection of risk factors of cardiac disease, such as a heart rate above 100 beats per 
minute (tachycardia); atrial fibrillation; cyanosis; clubbing; murmur; orthopnoea; and a 
dry cough. The authors emphasised the importance of observing the above mentioned 
signs and symptoms and referring patients for further investigation, if identified.  
As revealed by the above preliminary literature review, it is clear that few studies have 
been done to investigate the heart rate in cardiovascular conditions related to 
maternal adverse outcomes. The researcher expressed interest to the prevalence of 
maternal tachycardia during late pregnancy and its association with anaemia and 
major cardiac disease and/or complications. This research focused on the prevalence 
of increased heart rate, also known as tachycardia, in the pregnant mother during late 
pregnancy (34 to 38 weeks gestation as tachycardia was noticed during the Monica 
AN24™ recordings done at this gestation) and understanding the complications 
thereof.  
1.1.1.1 Ancillary study: Prevalence of maternal tachycardia during late 
pregnancy 
This particular study is an ancillary research project from the main research project 
called the Safe Passage Study, which is an ongoing study on the role of prenatal 
alcohol exposure in sudden infant death syndrome and stillbirths (PASS). It is an in-
depth study on the effects and role of prenatal alcohol exposure and its adverse 
outcomes on the pregnancy, the mother and the baby. This research project is 
community-linked and thus involved the direct members of the affected populations. 
This main research project is currently being conducted at two clinical centers namely, 
Cape Town, South Africa: Stellenbosch University; and the Northern Plains: Sanford 
Health/University of South Dakota. The principle investigators for the two centres are 
Hendrik Odendaal, M.D. (Cape Town), and Amy J. Elliott, Ph.D. and Larry Burd, Ph.D 
(South Dakota). Phase I of the main research project commenced in 2003 and phase 
II commenced August 2007 and is expected to be completed during 2014 (Ramirez, 
2008:1). The researcher proposed that during the course of Phase II of the main 
study, some of the data that was collected by means of the Monica AN24™ fetal 
monitoring device, be used for this particular study to examine the prevalence of 
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maternal tachycardia during late pregnancy, namely the 34 to 38 week gestation 
period.  
1.1.1.2 Monica AN24™ device 
The Monica AN24™ is a small (115 x 55 x 19mm), wireless, electronic monitoring 
device that is connected to the gravid abdomen by five high quality electrocardiogram 
(ECG) electrodes. Monica AN24™ amplifies ECG signals that pass through the 
abdominal wall to determine the fetal and maternal heart rates. Preparations of the 
participant (positioning of pregnant woman and cleaning of electrode sites, as well as 
placement of electrodes) and equipment setup are done in accordance with the 
Monica AN24 Protocol (2009:1). Four electrodes are placed in a diamond shape on 
the gravid abdomen below the umbilicus of the participant (while relaxing in a 
comfortable position on her back, slightly tilted, 15˚, to one side) and the fifth electrode 
lateral to the right. Recordings of the fetal heart rate, maternal heart rate and uterine 
activity last at least 30 minutes (Monica AN24, 2009:1).  
For the purpose of this study the researcher proposed to investigate the prevalence of 
maternal tachycardia during late pregnancy in greater detail and assessed its 
association with anaemia and major cardiac disease and/or complications. 
1.2 PROBLEM STATEMENT AND RATIONALE 
Resulting from the information in the previous paragraphs, the researcher was 
concerned that many of these conditions associated with tachycardia pass through the 
antenatal health care system without being noticed and investigated. As a 
professional nurse, the researcher observed a lack in the recording of the maternal 
heart rate at antenatal clinics. 
Because limited global and apparently no local research has been done on the 
prevalence of maternal tachycardia during late pregnancy, a gap in the lack of 
knowledge thereof was identified. For this reason the researcher was of the opinion 
that this study would be of significant importance. Therefore, the researcher proposed 
to investigate the prevalence of maternal tachycardia during late pregnancy in greater 
detail and would assess its association with anaemia and major cardiac disease 
and/or complications.  
1.2.1 Hypothesis  
The researcher intended to address the following research hypotheses formulated for 
this study: 
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• Maternal tachycardia in late pregnancy is associated with underlying major 
cardiac disease. 
• Maternal tachycardia in late pregnancy is associated with maternal anaemia. 
• Maternal tachycardia in late pregnancy is associated with adverse maternal 
and perinatal outcomes.  
1.2.2 Aim of this research  
The aim of this study was to determine the prevalence of maternal tachycardia during 
late pregnancy and its association with anaemia, major cardiac disease and/or 
complications and adverse maternal and perinatal outcome.  
1.2.3 Objectives  
The objectives of this exploratory study were to:  
• determine the prevalence of maternal tachycardia at 34 to 38 weeks gestation 
in a sub-population of patients enrolled in the Safe Passage Study; 
• compare the empirical findings with a control group of normal maternal heart 
rates during late pregnancy; 
• determine whether the presence of anaemia is common in maternal 
tachycardia; 
• explore whether any underlying, pre-existing cardiac condition could be 
identified; 
• determine the perinatal outcomes of pregnancy preceding, during, and after 
birth, in those patients presenting with maternal tachycardia; and 
• determine maternal morbidity/mortality associated with anaemia and major 
cardiac disease and/or complications. 
1.3 RESEARCH METHODOLOGY  
1.3.1 Research approach and design 
A quantitative research approach was selected to determine the prevalence of 
maternal tachycardia during late pregnancy and to determine the association between 
anaemia and cardiac lesions and also to compare it with a control group of normal 
maternal heart rates during late pregnancy. According to Burns and Grove (2009:22), 
quantitative research is a formal, objective, and systematic process in which numerical 
data are used to obtain information about the world.  
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Polit and Beck (2010:74) describes research design as the overall plan for obtaining 
answers to questions being studied and for handling various challenges pertaining to 
the value of the study evidence. This particular study was a case-control retrospective 
study within a prospective study because the researcher would analyse already 
collected data. An explorative and correlation research design was selected. Burns 
and Grove (2009:25) explain that correlation research involves the systematic 
investigation of relationships between or among two or more variables that have been 
identified in theories, observed in practice, or both. This type of design was thus best 
suited for the aim and objectives of the study. 
1.3.2 Target population and sampling  
A population refers to a term that sets boundaries on a study and includes individuals 
in the universe who possess specific characteristics (De Vos, Strydom, Fouche & 
Delport, 2009:193). 
The population that were included from the main study was all the participants that 
were recruited during Phase II of the main study, between 20 July 2009 and 4 July 
2011, to ensure that all the participants have delivered and have been discharged 
from hospital. According to the Safe Passage Study, Tygerberg Hospital statistics, 
2097 participants were recruited during that time span. Of the 2097 participants, a 
total of 1431 Monica AN24™ routine recordings between 34 and 38 week’s gestation 
were examined. These participants have completed delivery and have been 
discharged from hospital by the time the researcher completed data collection. These 
participants’ recordings were examined to determine the overall prevalence of 
maternal tachycardia, thus forming the target population for this ancillary study 
(N=1431).  
Arkava and Lane, as cited in De Vos et al. (2009:194), describe a sample as 
“elements of the population considered for actual inclusion in the study”. The 
researcher opted for one type of sampling, namely:  
• a non-probability, purposive sample (n=102) was used to select the 
participants presenting with maternal tachycardia to form the case group. This 
type of sample is “based entirely on the judgement of the researcher in that a 
sample is composed of elements which contain the most characteristic, 
representative or typical attributes of the population” (De Vos, 2001:198); and  
• the control group was also selected by means of a non-probability, purposive 
sampling. After each case of maternal tachycardia was identified in the above 
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case group, the following participant - provided that maternal tachycardia was 
NOT present - was selected in a consecutive manner following the selection of 
each participant in the case group (n=102) to exclude possible environmental 
temperature changes that might have an influence on maternal heart rate as 
mentioned earlier.  
In general it is stated that the larger the population, the smaller the percentage of that 
population’s sample size needs to be. Based on Stoker’s table (1985) (cited in De 
Vos, 2001:192), the researcher selected just over 14% of the population for the 
sample (thus 14.25%) for both the case group (n=102), and the control group (n=102) 
(N=1431 X 14.25% = 204 ÷ 2 = n=102).  
1.3.3 Inclusion and exclusion criteria 
The participants that were selected should have complied with the following criteria: 
1.3.3.1 Inclusion criteria 
To be included in this study, the participants: 
• were recruited between 20 July 2009 and 4 July 2011; 
• had a 34 to 38 weeks gestation Monica AN24™ recording; 
• had at least 20 minutes of rest before recording was started; and  
• had a recording done whilst lying on their back at 15˚ angle on her left or right 
side. 
1.3.3.2 Exclusion criteria 
Participants were excluded from this study if: 
• they were recruited before 20 July 2009 and after 4 July 2011; 
• any external factors were present that might have caused maternal 
tachycardia, e.g. latent labour; smoking in last 20 minutes before recording 
started; and  
• they had exercised and ate in last 30 minutes before the recording was 
started. 
1.3.4 Data collection instrument 
In this study, a computerised Microsoft Excel spreadsheet was compiled by the 
researcher to collect the entire participant data set needed for the purpose of this 
study. This spreadsheet was designed to collect all the relevant information regarding 
the proposed study and the researcher herself entered the data. The items on the 
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spreadsheet were based on the research objectives set for this study, as well as 
reviewed literature.   
The items on the spreadsheet were divided into different sections (columns) pertaining 
to each statement. Some of the statements required a “yes” or “no” answer. Other 
statements required a closed-ended answer to be selected from specified response 
options in a drop down menu on the spreadsheet. There were no statements that 
required open-ended answers.  
A statistician from Stellenbosch University’s Statistical Department was consulted 
regarding the content and feasibility of the designed data collection instrument. The 
statistician also provided advice regarding the description of the study and comparison 
of the findings between the case group and control group.  
1.3.5 Pilot study  
A pilot study is defined by Burns and Grove (2007:38) as “a smaller version of a 
proposed study, and it is conducted to refine the methodology” of the study. The 
researcher did a pilot study by means of a pre-test of the data collection instrument 
and analysis of data before commencement of the main study. Leon, Davis, and 
Kraemer (2011:626) asserts that “the fundamental purpose of conducting a pilot study 
is to examine the feasibility of an approach that is intended to ultimately be used in a 
larger scale study”. This was done by the random selection of the participants’ 
information that was then used to complete, and test the data collection instrument by 
the researcher herself. The participants involved in the pilot study were selected from 
the same population as the main study. The information collected from the pilot study 
was not included in the main study or final data analysis and results.  
According to Dawson and Trapp (2004:289), a large sample is not required to test an 
instrument; therefore a sample size of 1% (n=16) of the population sample (n=204) 
was included in the pilot study to determine any possible changes or modifications to 
the data collection instrument until the instrument efficiently measured the required 
objectives set for the study.   
1.3.6 Reliability and validity  
The reliability of a measuring instrument refers to the consistency of measures 
obtained in the use of a particular instrument and it indicates the extent of random 
error in the measurement method (Burns & Grove, 2009:377). Thus, the measured 
variables should measure the exact measurements if it is measured under the same 
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conditions each time. Along with the pilot study, the reliability of this study was also 
ensured by pre-testing the data collection instrument as it was tested under the exact 
same circumstances as the actual study. 
De Vos et al. (2009:160) explain that the validity of an instrument measures the 
concept in question, and whether the concept is measured accurately. Thus validity 
refers to the extent to which an empirical measure accurately reflects the concept it is 
intended to measure. Face validity in this study was ensured by means of subjective 
judgements by experts in research methodology about the degree to which the 
instrument appeared to measure the relevant variables. Content validity in this study 
was assured by means of opinions of experts to validate the instrument (De Vos et al., 
2009:162). A statistician checked whether all the variables could be analysed 
statistically. Furthermore, the variables included in the data collection instrument were 
based on the objectives that were set for this study as well as a comprehensive 
literature review on the topic.  
1.3.7 Data collection 
Data collection was done by the researcher by means of a self-designed, 
computerised Microsoft Excel spreadsheet. The great advantage of the nature of this 
type of collection was that the researcher could collect the data in her own time. There 
was no need to make any physical contact with the participants, for the reason that all 
the data had already been collected by the Safe Passage Study. The researcher 
collected the data from the Monica AN24™ recordings’ downloaded files as well as 
the copied hospital notes of each patient. The process of data collection continued 
until the sample reached the designated size, namely 102 participants for the case 
group and the control groups respectively. 
Data collection took place from the 1st of August 2011 and was completed by the 20th 
of November 2011. The selected participants’ data was only collected for one of the 
groups, namely either the case or control group according to the inclusion and 
exclusion criteria. Therefore, the same participants’ data could not have been used 
more than once.  
The data collection took place in Tygerberg Hospital at the Safe Passage Study 
secured office where the data is currently stored. The collected data for this study is 
stored on the researcher’s private computer and a back-up copy is saved on a 
separate hard drive that is locked in a cupboard to be kept safe. 
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1.3.8 Data analysis and interpretation 
At the time of data collection there were six Monica AN24™ devices available at 
Tygerberg PASS unit. After collection of the participants’ data, the device was 
connected to the designated laptop computer with the DK 1.5b software to allow 
storage and analysis of the raw data. Subsequently, the files were sent from the 
laptop to a designated FTP directory on the local server from which they were 
downloaded on desktop computers for back-up and further analysis. This data was 
also copied on an external hard drive for analysis using the DK1.5b programme 
(Monica AN24, 2008:9). Additional information regarding the precise gestation at the 
time of data recording as well as delivery was obtained from maternal records at the 
research unit and manually added to the analysed data in Excel spreadsheet form. 
MS Excel was used to capture the data and STATISTICA version 9 (StatSoft Inc., 
2009) was used to analyse the data. Inferential statistical tests e.g. analysis of 
variance (ANOVA) was applied and the distributions of variables was presented with 
histograms and/or frequency tables. A statistician of Stellenbosch University was 
consulted for guidance regarding which inferential tests were appropriate. Univariate 
analysis was undertaken to establish whether association exists between cases and 
controls and the factors in the objectives such as maternal haemoglobin; anaemia; 
presence or absence of cardiac lesions or disease; presence or absence of infection; 
gestational age at delivery and birth weight. Where the factor was a continuous 
variable, a t-test was used. Contingency tables were used where factors in objectives 
were considered categorical. Multiple logistic regressions were used to determine the 
association of the factors with demographic variables.  
1.3.9 Ethical considerations 
According to the Department of Health (2004:3) the purpose of ethical principles for 
health research in South Africa is to identify good, desirable and acceptable conduct, 
to protect the welfare and rights of research participants, and to reflect the basic 
ethical values of beneficence, justice and respect for persons. The researcher 
protected the research participants by ensuring that the following criteria were met: 
• A waiver of informed consent for this sub-study has been obtained based on 
the fact that all study procedures fall under the umbrella of the main study for 
which consent had already been obtained. The researcher explored already 
collected data, as well as the hospital records of the participants.  
• There were no risks involved regarding the participation in this study. 
Confidentiality, privacy and anonymity were assured by separating the 
participants’ consent form with their identity and their data files and not 
disclosing any information to others. 
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• Each data file for this sub-study was identified by a unique study code number 
known only to the researcher. 
• The participants were only selected if they complied with the inclusion criteria 
of this study to assure their eligibility to take part in this sub-study. 
Stellenbosch University  http://scholar.sun.ac.za
13 
 
1.4 STUDY OUTLAY  
The outline of this research report is as follows: 
Chapter 1: Scientific foundation of the study 
A general overview of the research was given in this chapter. The overview included 
an introduction to the research topic, the rationale, hypothesis and problem statement, 
as well as the aim and objectives for the study. The methodology of the study was 
briefly explained and the ethical considerations were discussed in depth. 
Chapter 2: Literature review 
In this chapter, increased maternal heart rate, haemoglobin and anaemia and 
contributing factors to tachycardia were clarified. The concepts of the role and 
responsibilities of the midwife in antenatal care were also discussed. In addition, 
previous relevant research studies were reviewed and discussed. 
Chapter 3: Research methodology 
The research approach and design, selection of subjects for the sample, the data 
collection methods and process, as well as the data management were explained in 
detail in this chapter. 
Chapter4: Data analysis and results 
The analysis and interpretation of the findings were discussed in detail in this chapter. 
Chapter 5: Conclusions and recommendations 
This chapter contains the conclusions and recommendations of the study. 
1.5 SUMMARY 
A preliminary literature review was done on the prevalence of maternal tachycardia 
during late pregnancy and its association with anaemia and major cardiac disease 
and/or complications. The researcher experienced a lack of information and therefore 
identified a gap in research regarding this topic. There was no adequate information 
known about the prevalence of maternal tachycardia in the Western Cape and 
whether there was an association with anaemia and cardiac disease and/or 
complications. Recommendations were made regarding maternal heart rate 
monitoring during late pregnancy in relation to identifying possible underlying 
problems.  
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In this chapter, a general overview was given about the proposed research problem. 
The research was explained in the context of the research process as well as the 
steps that were followed to achieve the aim and objectives set for this study. 
Therefore it was clear that research was necessary to gain more information regarding 
maternal tachycardia in order to identify whether something could be done to ensure 
better maternal and perinatal care. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 INTRODUCTION 
Optimal maternal health during pregnancy is essential for the good outcome of both 
mother and baby. In antenatal care, the focus should therefore be on the health and 
well-being of the fetus as well as that of the mother. Healthcare workers should be 
aware of signs or symptoms that are encountered during routine antenatal care that 
could indicate an underlying disorder. 
A literature review was done based on the objectives set for this study as discussed in 
chapter 1. The literature study was done via an internet search on various databases, 
namely MD Consult; Google Scholar; Pubmed; Science Direct; Scopus; and Cinahl. 
The following code words and combinations of keywords were used as a search for 
relevant data, namely physiological changes during pregnancy; cardiovascular; 
maternal heart rate; haemoglobin changes; anaemia; prevalence of maternal 
tachycardia during late pregnancy; contributing factors to tachycardia; exercise and 
tachycardia; pain causing tachycardia; fever/pyrexia causing tachycardia; anxiety 
causing tachycardia; pathologic conditions causing tachycardia; hypovolaemia 
causing maternal tachycardia; tachyarrythmia causing maternal tachycardia; 
thyrotoxicosis causing maternal tachycardia; hypoxaemia causing maternal 
tachycardia; hypotension causing maternal tachycardia; substance misuse; smoking, 
alcohol abuse; substance abuse; and contributing causes of maternal tachycardia. 
Sources were mainly chosen according to their publication dates (2006-2011) and 
relevance to the topic. References dated before 2006 were only included where no 
recent publications were found. 
Of particular interest for this study were the numerous changes in the maternal 
cardiovascular system. One of these, namely the increase in heart rate, deserves 
special attention, as an excessive increase in the heart rate, or tachycardia, could 
indicate underlying medical conditions, such as anaemia or heart failure (Woods, 
2006:5). This particular study focused on the prevalence of maternal tachycardia as 
observed during prenatal evaluations.  
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2.2 PHYSIOLOGICAL CHANGES DURING PREGNANCY 
2.2.1 General changes 
During the course of pregnancy, almost every organ and system undergoes 
anatomical and functional changes to accommodate the developing fetus (Sela, Hen 
& Einav, 2011:69; Carlin & Alfirevic, 2008:801). As mentioned previously, these 
systems and organs include the skin; reproductive organs; cardiovascular, 
haematological, renal, musculoskeletal, neurological, gastrointestinal; respiratory; 
endocrine; immune; respiratory; and alimentary systems; as well as the general 
metabolism (Sammaritano, 2010:729; Quigley, 2007:879; Carlin & Alfirevic, 
2008:804). In order to achieve optimal pregnancy outcomes, it is essential to 
understand the normal physiological changes that occur.  
For the purpose of this study only the cardiovascular changes during pregnancy were 
discussed in detail.  
2.2.2 Cardiovascular changes during pregnancy 
The most profound physiological changes take place in the cardiovascular system. 
The physiological changes in pregnancy facilitate the adaptation of the cardiovascular 
system to the increased metabolic needs of the mother and the developing fetus. The 
majority of the cardiac changes arise in the first trimester and plateaus by mid-
gestation, peaking again around the time of delivery (Carlin & Alfirevic, 2008:802).  
The heart facilitates the provision of oxygen and nutrients and the removal of carbon 
dioxide and wastes to and from all the organs. Shah (2007:24) explains that the main 
determinants of oxygen delivery include the amount of oxygen carried by the blood 
and the delivery of the blood, called the cardiac output. The amount of oxygen carried 
by the blood is determined by the concentration of haemoglobin and the degree of 
oxygen saturation of haemoglobin. 
2.2.2.1 Changes in cardiac output and blood pressure  
During pregnancy, the cardiac output increases gradually by 30% to 50% (Tan, 
2010:107; Maroo & Raymond, 2010:224) and peaks between 20 and 24 weeks of 
gestation (Gelson & Johnson, 2010:608), as a result of the increase in both stroke 
volume and heart rate (Gelson & Johnson, 2010:608; Swanton & Banerjee, 
2008:526). This rise in cardiac output begins in early first trimester and reaches 
maximum values by mid-gestation (Tan, 2010:107). However, the systolic and 
diastolic blood pressure decreases in the first trimester by about 10 mm Hg, reaching 
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its lowest levels at about 20 weeks of gestation (Swanton & Banerjee, 2008:527). 
Systolic blood pressure decreases by 5 to 10 mm Hg and diastolic blood pressure 
decreases by 10 to 15 mm Hg during the mid-second trimester of during pregnancy. 
This increased blood pressure levels return to baseline levels by the late third 
trimester (Flack, Ferdinand, Nasser & Rossi, 2010:626). 
Table 2.I indicates the haemodynamic changes that occur during the pregnancy, 
peripartum and postpartum period of women. This table shows the increase or 
decrease in the blood volume; systolic blood pressure; diastolic blood pressure; 
systemic vascular resistance; heart rate; stroke volume; and cardiac output. The 
arrows’ pointing up or down in the particular table suggests whether there is an 
increase or decrease in the change during the particular period.  
Table 2.1: Hemodynamic changes during pregnancy, peripartum and 
postpartum 
Change Pregnancy Peripartum Postpartum 
Blood volume    
Systolic blood pressure    
Diastolic blood pressure    
Systemic vascular resistance    
Heart rate    
Stroke volume    
Cardiac output    
(Source: Silversides & Colman as cited in Oakley & Warnes, 2007:7)  
2.2.2.2 Maternal heart rate during pregnancy 
An increase in maternal heart rate, which occurs from 4 weeks of gestation, is one of 
the earliest cardiovascular changes that occur during pregnancy (Tan, 2010:107). 
During the course of pregnancy, the mean maternal heart rate usually increases by an 
average of 10 to 20 beats per minute (Oakley & Warnes, 2007:12; Camm, Lüsher & 
Serruys, 2006:608; Hill & Pickenpaugh, 2008a:392). Maroo and Raymond 
(2010:224) also reveal that heart rate only increases by 10 to 15 beats per minute.  
The onset of this increase in maternal heart rate is within the first few weeks of 
pregnancy and peaks at about late second or early to the first half of the third trimester 
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(Oakley & Warnes, 2007:12; Camm et al., 2006:608). Easterling and Stout (2007:914) 
explain that after 32 weeks of gestation, due to the fall in stroke volume, the 
maintenance of the cardiac output becomes more and more dependent on the heart 
rate, thus being a compensatory response. 
A rise in heart rate leads to a decreased time for diastolic filling and can lead to 
reduced cardiac output and perfusion pressures (Carlin & Alfirevic, 2008:802). As 
indicated in figure 2.1, there is an increase in heart rate (HR), stroke volume (SV) and 
cardiac output (CO) during pregnancy up to the 38th week of gestation.  
 
Figure 2.1: Heart rate, stroke volume and cardiac output in pregnancy  
(Source: Presbitero, Boccuzzi, De Groot & Roos-Hesselink, 2006:608) 
Figure 2.2 is an illustration of how an initial stimulus such as exercise or low blood 
pressure stimulates the sympathetic nervous system to increase the SV and HR and 
therefore, also cardiac output. 
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Figure 2.2: Factors involved in the regulation of cardiac output 
(Source: Marieb, 2004:701) 
2.2.3 Circulatory changes during pregnancy 
Sela et al. (2011:61) summarise the physiological changes in the blood circulation 
during pregnancy as an increase in plasma volume and erythrocyte count; increased 
concentrations of most clotting factors; hormonal changes leading to cardiovascular 
effects, and effects secondary to uterine growth. The authors mention that due to the 
hormonal changes leading to cardiovascular effects, simulating exercise results in an 
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increased heart rate that could cause borderline physiologic tachycardia. For the 
purpose of this study only the haemoglobin changes and anaemia during pregnancy 
will be discussed briefly. 
The normal range of haemoglobin values for non-pregnant women is between 12 and 
16 g/dl and between 11 and 14g/dl for pregnant women (Blackburn, 2007:228). The 
lower end for the normal haemoglobin range in pregnancy is 11 to 12 g/dl (Carlin & 
Alfirevic, 2008:804). The World Health Organization (WHO) defines anaemia of 
pregnancy as a haemoglobin level of less than 11 g/dl, or a hematocrit less than 33%, 
at any point during pregnancy (WHO, 2001:33). Maroo and Raymond (2010:223) 
explain that this phenomenon occurs when the rise in blood volume of about 40% to 
50% is greater than the increase in red blood cell mass and this contributes to the fall 
in the haemoglobin concentration during pregnancy. Thus, the maternal haemoglobin 
levels declines progressively from the first to the eighth month of gestation, then 
increases in the month before delivery (Lee & Okam, 2011:244). The plasma volume 
increases by a lesser amount in the last month of pregnancy, leading to a decrease in 
the intensity which thus causes the haemoglobin value to increase. 
The common maternal signs and symptoms of anaemia include tachycardia, pallor, 
tachypnea, glossitis, fatigue, paresthesias, and headaches (Laubach & Bendell, 
2008:2385); but according to Feisullin (2006:86) women are usually asymptomatic 
unless their haemoglobin value is less than between 6 to 7 g/dl.  Laubach & Bendell, 
2008:2385) claims that haemoglobin levels less than 6 g/dl in pregnant women can be 
associated with significant maternal and fetal complications because at these levels, 
tissue oxygenation decreases and may lead to a state of high-output congestive heart 
failure in the mother.  
Comparing the views of the WHO (2001) and Lee and Okam (2011:242) it is clear that 
anaemia in pregnancy primarily affects women of a low socio-economic status and the 
risk of anaemia in pregnancy increases with the progression of the pregnancy. As 
noted by Laubach and Bendell (2008:235), previous studies have revealed a 
correlation between maternal anaemia and increased rates of both preterm (less than 
37 weeks of gestation) and low birth weight deliveries. The author contends the 
importance to consider factors such as maternal nutrition and health; socio-economic 
conditions; and environmental influences that can independently affect pregnancy 
outcomes. The most common cause of anaemia during pregnancy is iron deficiency 
(Feisullin, 2006:87; Laubach & Bendell, 2008:2385; Woods, 2006:4). A study done to 
determine risk factors for birth outcomes and contributions of the populations to parts 
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and/or changes or findings, concluded that anaemia and maternal malaria continue to 
be significant causes of adverse pregnancy outcome in sub-Saharan Africa. This 
study also revealed that 63% of stillbirths were estimated as being attributable to 
maternal anaemia (Watson-Jones, Weiss, Changalucha, Todd, Gumodoka, Bulmer, 
Balira, Ross, Mugeye, Hayes & Mabey, 2007:9). 
2.3 PREVALENCE OF MATERNAL TACHYCARDIA DURING 
PREGNANCY 
A broad literature review was done on the title of the study and the researcher did not 
find any published articles with the same title or focus within the last five years. 
However, a number of studies have listed tachycardia as one of the normal 
cardiovascular signs that occur in pregnancy (Tan, 2010:108; Hill & Pickenpaugh, 
2008a:394; Sammaritano, 2010:735). Carson, Powrie and Rosene-Montella (2002:40) 
found that 39% of healthy, asymptomatic patients in the third trimester of pregnancy 
had sinus tachycardia when in the seated position. This study found that 29% of the 
tachycardia cases were positioned on their left side. However, Zentner, Du Plessis, 
Brennecke, Wong, Grigg and Harrap (2009:603) emphasise a number of potential 
pathways or factors that can place stress on the cardiovascular system such as 
autonomic nervous system activation; insulin resistance; relative tachycardia; 
anaemia; and weight gain.  
Reide and Yentis (2010:315) are of the opinion that all pregnant women are prone to 
tachycardia and arrhythmias, of which, in most cases, the symptoms are absent or 
mild, but in women with pre-existing cardiac disease the symptoms may be profound 
and severe. Although previous researchers have revealed that tachycardia during 
pregnancy is relatively normal, awareness thereof should not be ignored.  
2.4 CONTRIBUTING FACTORS TO TACHYCARDIA  
Tachycardia is a symptom of an underlying condition. Marschlinski, Fauci, Braunwald, 
Kasper, Hauser, Longo, Jameson and Loscalzo (2009:4) explain that tachycardia 
represents a physiological response to a variety of stresses and when a demand is 
placed on the heart, such normal or appropriate response to stress occurs as a result 
of either exercise; pain; anxiety; or pyrexia. It is also stated that pathologic conditions 
such as volume depletion, thyrotoxicosis, hypoxaemia, hypotension, congestive heart 
failure, drugs, and tachyarrhythmia can also cause tachycardia. Contributing causes 
of tachycardia of interest for this study, namely exercise; pain; pyrexia (fever); anxiety; 
and relevant pathologic conditions, are briefly described as follows. 
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2.4.1 Exercise  
Exercise during pregnancy has proven to be beneficial for both the mother and the 
fetus. The physiological responses to exercise are increased oxygen consumption, 
redistribution of blood, altered venous pooling, as well as changes in the cardiac 
output and stroke volume, which thus causes the cardiac workload to increase 
(Blackburn, 2007:277). Exercise as a crisis stressor, stimulates the sympathetic 
nervous system activity that causes the heart rate to increase that ultimately elevates 
the cardiac output (Marieb, 2004:701). Zentner et al. (2009:600) suggest that the 
sympathetic hyper-reactivity in pregnancy is likely to contribute to an increase in the 
heart rate with activity and inadequate rest may cause confusing measurements.   
A study was done in Canada to develop and validate a prediction equation for peak 
oxygen consumption by using a progression treadmill test and to refine the current 
target heart rate exercise guidelines for pregnancy (Mottola, Davenport, Brun, Inglis, 
Charlesworth & Sopper, 2006:1392). They found that the fit women in their cohort 
study had the aerobic capacity to have an average maximum heart rate of 180 (± 2 
beats per minute) at 16 weeks gestation using a treadmill. The article addressed the 
peak oxygen consumption in pregnancy only and did not refer to tachycardia as such. 
The researchers support the current target heart rate zones of the Canadian Society 
for exercise guidelines (Canadian Society for Exercise Physiology, 2002), which 
entails that active women between 20 and 29 years of age can safely exercise with 
heart rates ranging between 135 to 150 beats per minute. Mottola et al. (2006:1391) 
add that this heart rate prescription should be coupled with a “talk test” which allows 
the pregnant women to carry out a conversation without being out of breath. A 
physical activity readiness medical examination (PARmed-X) for pregnancy is a 
guideline for health screening prior to participation in a prenatal fitness class or other 
exercise (Canadian society for exercise physiology, 2002).  
Although pregnant women with a fast heart rate should maintain moderate exercise 
during pregnancy, adequate rest during periods of tachycardia is important to avoid 
stress (Quinlan, 2011).  
2.4.2 Pain 
A thorough literature search was done (MD Consult; Google Scholar) to explore “pain” 
as a contributing cause of tachycardia, but limited information was found. Pain is 
defined by Mosby’s Dictionary (2009) as “an unpleasant sensation caused by noxious 
stimulation of the sensory nerve endings; a subjective feeling and an individual 
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response to the cause”. It is a cardinal symptom of inflammation and is valuable in the 
diagnosis of many disorders and conditions. Pain can be experienced as mild, 
moderate or severe, chronic or acute, burning, dull or sharp, precisely or poorly 
localized, or identified as a referred (reflective) pain (Mosby’s Dictionary, 2009). It is 
possible that pain can cause tachycardia as the stimulation of the sympathetic 
nervous system causes a rise in the blood pressure and heart rate (Mendelson, 
2005:398). 
It is important to establish the cause of pain and treat it as soon as possible, because 
the etiology thereof could be dangerous to not only the pregnant woman, but the fetus 
as well. There are many causes of pain and therefore the health care provider should 
do the necessary examinations and investigations once a patient verbalises or 
presents with any degree of pain.  
2.4.3 Pyrexia 
A thorough literature search was also done (MD Consult; Google Scholar) regarding 
“fever” as a contributing cause of tachycardia in pregnancy but limited information was 
found. The abnormal rise in body temperature that frequently accompanies disease in 
general, is defined as fever or pyrexia (Black's Medical Dictionary, 2010). A common 
cause of fever in pregnancy is a maternal infection for example chorioamnionitis; 
urinary tract infection (UTI); upper respiratory tract infection (URTI); and septicemia 
(Apantaku & Mulik, 2007:12).  
Snyder, Crawford and Jamieson (2007:401) avers that tachycardia in a febrile 
pregnant woman should prompt treatment for chorioamnionitis, even if she’s already 
on antibiotics for group B streptococci. Clinical chorioamnonitis is defined as the 
presence of maternal fever greater than 38˚C. Maternal tachycardia (pulse rate of 100 
beats per minute for 5 minutes) is one of the diagnostic signs for chorioamnionitis. The 
non-infective causes of fever during the intra-partum period are excessive pain; 
epidural analgesia; hot delivery room; and dehydration (Apantaku & Mulik, 2007:12). 
Therefore, the punctual monitoring of maternal observations should remain a high 
priority. 
2.4.4 Anxiety 
Anxiety is defined by Mosby’s Dictionary (2009) as “the anticipation of impending 
danger and dread accompanied by restlessness, tension, tachycardia, and breathing 
difficulty not necessarily associated with an apparent stimulus”. Anxiety is also part of 
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a crisis stressor as illustrated in figure 2.2, which stimulates the sympathetic nervous 
system activity and in effect elevates the heart rate.  
A literature search was done via Science Direct and Google Scholar regarding the 
effects of maternal anxiety on the maternal heart rate and in particular maternal 
tachycardia in late pregnancy. To the researcher’s knowledge, little is known and 
limited information was found in the literature about the effects or outcome of maternal 
anxiety on maternal heart rate. However, plenty of studies have been published that 
include the effects of maternal anxiety on the fetal heart rate (DiPietro, Costigan, 
Nelson, Gurewitsch & Laudenslager, 2008:11; DiPietro, 2010:27; Monk, Sloan, Myers, 
Ellman, Warner, Jeon, Tager & Fifer, 2004:283).  
A review was done on studies that have used physiological stress reactivity in 
pregnant women and have concluded that physiological stress reactivity appears to be 
dampened during pregnancy (De Weerth & Buitelaar, 2005:295). Thus, consequences 
of stress such as changes in blood pressure, pulse rate and cortisol levels appear to 
be reduced in pregnancy. This particular study confirmed that physiological responses 
to laboratory challenges are present and thus enabled the study to make links 
between responsivity patterns, psychosocial variables, fetal behaviour, pregnancy 
outcome and offspring development. DiPietro et al. (2008:11) are of the opinion that 
maternal experiences create a cascade of physiological and neurochemical 
consequences that may alter the intra-uterine environment either directly or indirectly 
and thereby generate a fetal response. Researchers that studied maternal 
performance on a stressful mental arithmetic challenge observed that both maternal 
heart rate and fetal heart rate increase during maternal stress (McCubbin, 2009:174).  
2.4.5 Pathologic conditions causing tachycardia 
There are various pathologic conditions, abnormal anatomical or physiological 
conditions that cause tachycardia. The conditions discussed in the following section 
are chosen because of their relevance to maternal tachycardia, namely hypovolaemia, 
hypoxaemia, hypotension, thyrotoxicosis as well as the effects of medication or 
substance misuse, congestive heart failure, tachyarrhythmia and other underlying pre-
existing cardiac conditions.  
2.4.5.1 Hypovolaemia  
Hypovolaemia, or volume depletion, is defined as an abnormally low volume of blood 
circulating in the body (Penguin English Dictionary, 2007). The developing signs of 
hemodynamic instability are hypotension and tachycardia (Katorza, Soriano, 
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Stockheim, Mashiach, Zolti, Seidman, Schiff & Goldenberg, 2007:501). According to 
Hill and Pickenpaugh, 2008b:422) pregnant women can lose 30% to 40% of blood 
volume (haemorrhage) before changes manifest in the heart rate and/or blood 
pressure. Maternal haemodynamic instability could present with symptoms such as 
hypotension and tachycardia, which are considered as threatening indicators. Cooper 
and McClure (2008:20) identified certain remediable factors such as poor recognition 
of concealed intra-abdominal bleeding as a problem. The latter further emphasises 
that the classical signs related to intra-abdominal haemorrhage such as tachycardia 
and tachypnea are still being ignored. Thereby the early recognition of hypovolaemia 
and correct interpretation of the vital signs play an important role in what the outcome 
of a patient’s state of wellbeing may be. Antenatal women presenting with these 
symptoms usually require immediate intravenous fluid admission, fluid resuscitation, 
and possibly the administering of blood products (Sakornbut, Leeman & Fontaine, 
2007:1199).  
Hyperemesis gravidarum, or severe morning sickness in pregnancy, could be the 
cause of dehydration and volume depletion (Cheng, Montalto & Leff, 2009:82). 
Cuckson and Germain (2011:80) mention that nausea is experienced by 90% of 
pregnant women and 50% of pregnant women complain of vomiting. The authors list 
the signs of hyperemesis gravidarum as weight loss; ptyalism or excessive secretion 
of saliva; muscle wasting; tachycardia; and postural hypotension.  
2.4.5.2 Hypoxaemia 
Hypoxaemia is defined as a blood oxygen saturation of less than 90% (Majumdar, 
Eurich, Gamble, Senthilselvan & Marrie, 2011:325) and is explained as an abnormal 
deficiency in the concentration of oxygen in arterial blood (Mosby’s Dictionary, 2009), 
thus better understood as decreased oxygen content in the blood. Due to the changes 
in the pulmonary physiology during pregnancy, pregnant women often complain of 
breathlessness and present with dyspnea (Morgan & Ernst, 2011:63). Pregnant 
women with a pre-existing pulmonary disease, such as asthma, suffer from chronic 
hypoxaemia (Aly, Nada, Ahmad, Mohamed, Massaro, Bathgate, Macri & Larson, 
2011:1). According to Hegewald and Crapo (2011:1) (citing Archer & Marx, 1978) 
pregnant women are more susceptible to the development of hypoxaemia during 
periods of apnea, such as during acute endotracheal intubation. Maternal hypoxaemia 
adversely affects the fetus as it can quickly result in a decreased oxygen content 
supplied to the fetus. Therefore, chronic hypoxaemia could lead to intrauterine growth 
restriction and low birth weight (Hardy-Fairbanks & Baker, 2010:160). Although blood 
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gas tests and oxygen saturation are not routinely done during antenatal visits, it is 
essential that vital signs such as pulse rate, respiration, blood pressure and 
temperature are measured at these routine visits.  
2.4.5.3 Hypotension  
Hypotension is defined as “an abnormal condition in which the blood pressure is not 
adequate for normal perfusion and oxygenation of the tissues. An expanded 
intravascular space, hypovolaemia, or diminished cardiac output may be the cause” 
(Mosby, 2009). Maternal supine hypotension syndrome occurs when the pregnant 
woman lies in a supine position. It causes the inferior vena cava and abdominal aorta 
to compress, resulting in a decreased venous blood return to the heart (Hill & 
Pickenpaugh, 2008a:392). Effectively the hypotension reduces stroke volume that 
may result in a 25% to 30% decrease in cardiac output, which causes symptoms such 
as pallor; sweating; tachycardia; nausea; vomiting; and changes to the mental status 
(Hill & Pickenpaugh, 2008a:392). 
Conditions such as cardiovascular and/or endocrine problems; dehydration; 
hypovolaemia or volume depletion; septicemia; anaphylaxis and poor nutrition could 
be possible causes of hypotension (Mayo Clinic, 2011). A study was done to 
investigate hypotension in pregnancy and its relation to pregnancy complications and 
birth outcomes. This study found no clinically important difference in the rate of 
preterm births and low birth weight newborns in pregnant women with or without 
hypotension (BÃ¡nhidy, Acs, PuhÃ & Czeizel, 2011:55). 
2.4.5.4 Thyrotoxicosis 
The term thyrotoxicosis refers to “the overactivity of the thyroid gland, leading to 
excessive secretion of thyroid hormones and resulting in increased basal metabolic 
rate” (Benders' Dictionary of Nutrition and Food Technology, 2006). During 
pregnancy, it is not only the size and activity of the thyroid gland that increases, but 
the thyroid-binding globulin and triiodothyronine levels that rise as well (Taber's 
Cyclopedic Medical Dictionary, 2009). Larsen, Davies, Schlumberger and Hay 
(2011:315) explains that the physiological changes during pregnancy entail an 
increase to the following: serum thyroxine-binding; plasma volume; iodine; thyroxin 
(T4) production; fetal thyroxin (T4) synthesis during second and third trimesters; as 
well as oxygen consumption by the fetoplacental unit, gravid uterus and the mother. 
Consequently, this causes an increase in the production of thyroxin which causes an 
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increase in the iodine requirements. The increased oxygen consumption causes an 
increased metabolic rate which results in a rise in the cardiac output.  
Fitzpatrick and Russell (2010:182) aver that patients with hyperthyroidism can present 
with resting maternal tachycardia and if untreated, the maternal complications could 
lead to thyroid storm, including arrhythmia and congestive heart failure. The possible 
maternal complications may include thyrotoxicosis crisis; pre-eclampsia; pregnancy-
induced hypertension; congestive heart failure; and postpartum thyroiditis (Luewan, 
Chakkabut & Tongsong, 2011:243). 
2.4.5.5 Medication and substance misuse  
A PubMed search was done on the following key terms: “smoking”; “alcohol abuse”; 
“substance abuse”; and “elevated heart rate”; “maternal tachycardia”; as well as “late 
pregnancy” with no time limit. Only one significant study done by Silva, Miller, Madden 
and Keegan (1987:144) was found that linked abnormal foetal heart rate pattern with 
severe intrapartum maternal ethanol intoxication. Furthermore a MD (Medical Doctor) 
Consult search (Melliere, 2012), using the same key words for the last 10 years, 
revealed few results but were insignificant for the purpose of this study. 
Rayburn (2007:567) points out that maternal tachycardia is one of the withdrawal 
symptoms of alcohol overdose and withdrawal in pregnant women. It is important that 
the health care professional is aware if a patient abuses any drugs. Rayburn 
(2007:567) tabulated a number of medical, obstetric, and behaviour patterns in 
pregnant women that could be suggestive of substance use, such as anaemia; 
arrhythmias; restlessness; agitation; and various infectious diseases. Some of these 
behavioural patterns include tachycardia as a possible sign, for example anaemia and 
arrhythmias.  
Habek (2007:866) claims that one of the effects of tobacco smoke on the placenta-
umbilical circulation manifests as foetal and maternal tachycardia and contends that 
the complication rate in pregnancy rises proportionally to the number of cigarettes 
smoked per day.  
No recent studies could be found on drug abuse as a contributing cause of 
tachycardia in pregnancy. However numerous earlier studies have revealed the 
adverse effects of cocaine abuse in pregnancy on the fetus, such as fetal tachycardia 
and hypertension (James & Coles, 1991:400). According to Smith and Deitch 
(1987:121) it is known that cocaine can cause maternal tachycardia. Medication such 
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as oxytocin and ephedrine may cause tachycardia and should be avoided if possible 
(Reide & Yentis, 2010:315). The central and peripheral effects of β-adrenergic drugs 
cause varying degrees of maternal tachycardia, peripheral vasodilatation, and 
hypotension (Greiss, 2008). 
2.4.5.6 Congestive heart failure 
Congestive heart failure is defined as an abnormal condition that reflects impaired 
cardiac pumping and the inability to maintain the metabolic needs of the body 
(Mosby's Dictionary, 2009). Its causes include myocardial infarction; ischemic heart 
disease; and cardiomyopathy. Failure of the ventricles to eject blood efficiently results 
in volume overload, ventricular dilatation, and elevated intracardiac pressure. 
Increased pressure in the left side of the heart causes pulmonary congestion. 
Increased pressure in the right side causes systemic venous congestion and 
peripheral oedema. Along with tachycardia, pregnant women with heart failure can 
present with symptoms such as worsening of the pulmonary or peripheral congestion, 
particularly dyspnoea; decreased oxygen saturation; excessive weight gain (due to 
peripheral oedema); and signs and symptoms of hypoperfusion such as hypotension 
and/or worsening of the mental status (Cruz, Briller & Hibbard, 2010:294). These 
signs can be difficult to recognise the disease in a pregnant woman, but suspicion 
should be raised with the presence of jugular venous distension; increased heart rate; 
and peripheral oedema (Cruz et al., 2010:294). Once any of these signs are 
recognised in a pregnant woman it should be either referred for further investigation, 
or be followed up by her next antenatal visit.  
In pregnant patients with congestive heart failure, the already depressed cardiac 
reserve is further exacerbated by a sudden increase in plasma volume, increased total 
sodium concentration, anxiety with tachycardia and other factors such as bacteriuria 
with associated fever or any other febrile illness (Akintunde & Opadijo, 2011:139).  
2.4.5.7 Tachyarrhythmia and other underlying pre-existing cardiac 
conditions 
Taber's Cyclopedic Medical Dictionary (2009) defines tachyarrythmia as any cardiac 
rhythm disturbance in which the heart rate exceeds 100 beats per minute. Newstead-
Angel and Gibson (2009) note that arrhythmia can present at any point in gestation, 
but are more likely to be exacerbated during periods of peak hemodynamic stress. 
Tan (2010:113) reveals that serious arrhythmia is uncommon in pregnancy. According 
to Maroo and Raymond (2010:227), premature atrial or ventricular complexes are not 
Stellenbosch University  http://scholar.sun.ac.za
29 
 
associated with adverse maternal or fetal outcomes. However, Tan (2010:113) reveals 
that it may be the first sign of heart disease and should be excluded by careful 
physical examination and further investigation if necessary.  
Tachycardia is evident in some arrhythmias such as paroxysmal supraventricular 
tachycardia (PSVT), atrioventricular nodal reentrant tachycardia, Wolf-Parkinson-
White syndrome and ventricular tachycardia. Pulmonary diseases such as thrombo-
embolic disease and rheumatic heart disease also present with tachycardia (Mosby's 
Dictionary, 2009). The most common arrhythmia in pregnant women is sustained 
PSVT. This condition is defined as any tachyarrhythmia with a heart rate above 120 
beats per minute (Heatly, 2009:58; Robins & Lyons, 2004:140). Hormonal changes, 
alterations in autonomic tone, increased hemodynamic demand, and mild 
hypokalemia (or hypopotassaemia) increase the incidence of cardiac arrhythmias in 
pregnancy (Gelson & Johnson, 2010:607). Some adverse events of women who 
experienced arrythmia during the antepartum period include prematurity; respiratory 
distress syndrome; small for gestational age; and congenital heart disease 
(Silversides, 2006:1209). Hyperdynamic state, the altered hormonal milieu, and 
underlying heart disease are potential risk factors in pregnancy that can encourage 
the development of arrythmia. (Pérez-Silva & Merino, 2011).  
The Confidential Enquiries into Maternal Deaths (NCCEMD) (Department of Health, 
2009:35) reported that pre-existing cardiac disease was the most common cause of 
maternal deaths under the category pre-existing medical disorders during 2005 to 
2007, which accounted for 6% of maternal deaths during this time span. This statistic 
was published in the Saving Mothers 2005-2007 report, which is the fourth report on 
confidential enquiries into maternal deaths in South Africa. Comparing the statistics of 
the third and fourth report, there is an increase in maternal morbidity and mortality due 
to pre-existing cardiovascular disease in South Africa (Department of Health, 
2009:12). Although relatively infrequent, women with cardiac lesions are at 
exceptionally high risk of death during pregnancy if the disease is not detected and 
managed appropriately. This report further recommends the training of all health care 
professionals regarding the screening for cardiac disease (Department of Health, 
2009:35).  
According to Nelson-Piercy (2011:109) heart disease, as classified under the indirect 
maternal deaths, remains the most common cause of indirect maternal deaths in the 
United Kingdom for the years 2006 till 2008. The latter also avers that all the women 
who died, had identifiable risk factors such as obesity; older than 35 years; parity 
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larger than 3; smoking; diabetes; pre-existing hypertension; and a family history of 
heart disease.  
2.4.5.8 Other contributing causes of tachycardia in late pregnancy 
While it is simply not plausible to measure all the parameters and factors that may 
influence maternal heart rate in late pregnancy, it is possible to obtain useful 
information about the prevalence of maternal tachycardia in the current study. Other 
factors have also been suggested to have a possible influence on maternal heart rate 
during late pregnancy, such as maternal weight and/or intrauterine growth retardation 
(IUGR) influenced by cardiovascular function (Davenport, Steinback & Mottolla, 
2009:341). These contributing factors are discussed briefly below.  
2.4.5.9 Maternal weight  
A study done by Carson et al. (2002:40) explored the effect of obesity and position on 
heart rate in pregnancy. This study’s corresponding rates of sinus tachycardia when 
seated for obese and non-obese pregnant women were respectively 58% and 29%. 
The researchers revealed that resting tachycardia during routine antenatal visits may 
be more common than was previously recognised, as the majority of obese pregnant 
women were tachycardic when in the seated position. The only abnormality that was 
found on examination and laboratory testing was a high body mass index (BMI) (The 
Penguin Dictionary of Psychology, 2009). 
2.4.5.10 Mode of delivery 
A study done to measure maternal heart rate changes during labour concluded that a 
higher cardiovascular strain on physically less active women may represent an 
increased cardiovascular risk during labour (Söhnchen, Melzer, Martinez de Tejada, 
Jastrow-Meyer, Othenin-Girard, Irion, Boulvain & Kayser, 2011:5). Furthermore, these 
authors revealed that there were no significant differences between the heart rates of 
women who delivered spontaneously compared to women with instrument-assisted 
deliveries (forceps or vacuum). However, they did not investigate maternal heart rates 
during caesarian section. The same study also found no significant heart rate 
differences in women that delivered with or without epidural anaesthesia (Söhnchen et 
al., 2011:4). 
2.4.5.11 Intrauterine growth restriction (IUGR) 
A study done by Bamfo, Kametas, Turan, Khaw and Nicolaides (2006:787) explored 
the maternal cardiac function in 107 women with normal pregnancies and 20 with fetal 
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growth restriction (FGR) or IUGR. They found that there was reduced systolic 
function, characterised by lower cardiac output, stroke volume, heart rate, ejection 
time and septal and lateral long-axis shortening in the pregnancies complicated by 
fetal growth restriction. Another study to investigate maternal cardiovascular function 
in pregnancies complicated by IUGR found the maternal heart rate to be lower in the 
IUGR pregnancies (Prefumo, Perini, Paini, Bonzi, Lojacono, Agabiti-Rosei & Frusca, 
2008:65). A following study comparing maternal cardiac function in women with IUGR 
to those small-for-gestational age (SGA) pregnancies (non-IUGR) found that maternal 
cardiac output (CO) was lower by 23% compared to the SGA group (Bamfo et al., 
2007:51). There was no association between maternal tachycardia and growth 
restriction.  
From the above discussion regarding contributing factors of tachycardia in late 
pregnancy it seems clear that it is important to record the pregnant woman’s heart rate 
in pregnancy. The Centre for Maternal and Child Enquiries (CMACE) mentions the 
following: “Carry out, record and act on basic observations for both low-risk and high-
risk women”; and “recognise and act on symptoms suggestive of serious illness, 
including sepsis. These are two of the eight recommendations made for midwifery 
practice as set out in chapter 13 of Saving Mothers’ lives 2006-2008 report in order to 
prevent maternal deaths in future (CMACE, 2006:149).  
According to the aim and objectives set for this study the contributing causes of 
maternal tachycardia discussed in this chapter is believed to be appropriate. Any 
contributing cause that does not comply with the aim and objectives of this study was 
therefore not discussed. 
2.5 THE ROLE OF THE MIDWIFE IN ANTENATAL CARE 
A midwife is a person, who is educated and competent to practice independently, 
assumes accountability and responsibility for such practice and is registered in terms 
of the Nursing Act (SANC, 2004:47). The South African Nursing Council (SANC) 
currently controls the midwifery education and practice in South Africa (SANC, 2011). 
The role of the midwife consists of independent, interdependent and dependant roles. 
It is comprehensive in nature including activities such as screening, referrals, 
therapeutic activities, emergency treatment, education, counselling and provision of 
family planning services (Abrahams, Jewkes & Mvo, 2001:241).  
The scope of practice of the midwife as explained by SANC (2004:49) is complete and 
extensive including the provision and management of care of all aspects that influence 
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the course of pregnancy, labour and puerperium. There are many other factors 
involving the scope of practice of a midwife such as the management and co-
ordination continuity of care within the health care team (SANC, 2004:50). In order to 
practice, the registered midwife, and/or auxiliary nurse should be aware and 
understand his/her interdisciplinary role within which she/he may practice. The role of 
the midwife is bound to legislation and it is important that all nurses should adhere to 
legislation. Protocol is dependent on legislation and the availability of human and/or 
physical resources. 
2.6 LEGISLATION 
2.6.1 Nursing Act and regulations 
The latest Nursing Act No. 33 of 2005, as well as the latest regulations to comply with 
this act, have been released. The researcher reviewed all the available regulations 
applicable to the topic related to this study. The South African Nursing Council 
(SANC) publishes regulations relating to the published scope of practice of persons 
who are registered and/or enrolled under the new Nursing Act, 2005 (SANC, 2011).  
The following paragraphs discuss what this act denotes.  
2.6.1.1 Nursing Act 
Chapter one of the Nursing Act No. 33 of 2005 discuss information regarding the 
SANC. Chapter two of the Act entails education, training, research, registration and 
practice of nurses. In this chapter it is clearly stated that a professional nurse must be 
qualified and competent to independently practice comprehensive nursing in the 
prescribed manner and level. The professional nurse must be able to assume 
responsibility and accountability for such practice. A midwife must be qualified and 
competent to independently practice midwifery in the manner and to the prescribed 
level. The midwife must also be capable to assume responsibility and accountability 
for such practice.  
The content of chapters three, four and five of this Act is not applicable and/or relevant 
to this particular study as it explains the powers of the Council with regard to 
professional conduct; offences by persons not registered; as well as general and 
supplementary provisions.  
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2.6.1.2 Regulations 
All the regulations available on the SANC website (SANC, 2012) were reviewed and 
the researcher concluded that Government Notice No. 2598, the regulation relating to 
the scope of practice of persons who are registered or enrolled under the Nursing Act, 
1978, have not yet been amended or repealed. In chapter two of this regulation it is 
stated that the registered nurse is responsible for the diagnosis, prescription, provision 
and execution of a nursing regimen so that patients’ needs can be met, by referring to 
a registered person. Chapter three clearly states that the monitoring of the vital signs 
and the reaction of the mother and child to disease conditions; trauma; stress; anxiety; 
medication; and treatment of the mother and child during pregnancy, labour and 
puerperium is part of the registered midwife’s duty. Chapter four of this regulation 
posits that the enrolled midwife is responsible for the control, promotion and 
maintenance of the blood pressure, temperature, pulse rate and fetal heart rate. 
Chapter five suggests that it is within the scope of practice of the enrolled nurse to 
monitor the vital signs and the observation of reactions to medication and treatment. 
Chapter six of the abovementioned regulation regarding scope of practice of enrolled 
nursing assistants, also includes the taking of the blood pressure, temperature, pulse 
and respiration of a patient.  
From the above detail it is clear that it is within all nurses’ scope of practice and their 
responsibility to measure the vital signs of the mother and baby throughout the 
pregnancy as well as during the intrapartum and postnatal period. 
Government Notice No. 425 relates to the approval of, and the minimum requirements 
for the education and training of a nurse (general, psychiatric and community) and 
midwife leading to registration (SANC, 1985). Course subjects such as fundamental 
nursing science and general nursing science includes the observation and monitoring 
of vital signs.  The programme objectives suggests that nurses are skilled in 
diagnosing of patients’ health problems and the planning, implementing and 
evaluation of therapeutic action and nursing care for the health service consumers at 
any point along their health/illness continuum in all stages of life. 
Government Notice No. 254 contains the detail of the programme for the diploma in 
midwifery leading to registration as a midwife (SANC, 1975). This regulation suggests 
that the curriculum of this course includes subjects to be taught in basic sciences; 
natural sciences; biological sciences; science of midwifery; preventive and promotive 
healthcare; and record-keeping. These subjects should be sufficient in providing the 
knowledge for nurses to provide quality continuous care.  
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Furthermore, Government Notice No. 212 (SANC, 1993) contains detail regarding the 
programme in clinical nursing science leading to registration of an additional 
qualification. Emphasis is placed on meaningful co-operation within the nursing and 
multi-disciplinary team in order to ensure proper referral to an appropriate registered 
person that forms part of the nurses’ responsibility.  
2.6.1.3 Protocol 
According to Pattinson (2005:ii) basic antenatal care protocols are written guidelines 
to direct the nurses within South Africa’s antenatal clinics regarding the referral criteria 
for certain conditions in pregnancy. The Basic Antenatal Care (BANC) protocol, as 
compiled by Pattinson (2005:i) is part of a quality improvement package that aims to 
bring together all the resources of the package and facilitate their use. This protocol is 
specific to a particular clinic (Department of Health, 2005). An example of this is the 
Parow Community Health Centre (CHC) protocol that dictates specific referral 
processes etcetera.  
As discussed under the heading “Contributing factors to tachycardia” (see the first 
paragraph under heading 2.4), tachycardia is a symptom of an underlying condition 
brought about, for example, by exercise, pain, fever, anxiety and some pathologic 
conditions. The mentioned protocol is written to guide healthcare professionals in 
dealing with complex conditions and when to refer patients to the appropriate leve of 
care.  There are written protocols for the proper management of the following 
conditions: hypertension; pre-eclampsia, including severe pre-eclampsia; malnutrition 
or obesity; moderate and severe anaemia; possible syphilis; unknown HIV status; 
possible HIV infection; positive HIV status; upper and lower urinary tract infection; 
vaginal discharge; very severe febrile disease; possible IUGR; possible multi-
pregnancy or macrosomic fetus; post-term pregnancy; possible intra uterine death 
(IUD) (Easmin, Nahar, Jahan, Rahim & Nila, 2011); high maternal age; possible 
uterine and/or fetal infection; and abused pregnant woman (Department of Health, 
2005). The mentioned protocols are necessary guidelines for referral criteria but in 
order to work efficiently, the researcher emphasises the importance of routine 
monitoring of the vital signs.  
One of the objectives of the BANC program is to relieve the demands that the 
antenatal clinics currently experience. The BANC visits consist of five antenatal visits 
and are aimed at the low-risk pregnancies. The first booking visit is quite 
comprehensive, which includes the obstetric, general and medical history; a physical 
examination that includes assessing the heart rate and abnormal heart murmurs if 
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any; as well as some investigations such as HIV test; rapid syphilis test; and a 
haemoglobin test. At each visit the maternal blood pressure, weight, mid-upper arm 
circumference and a urine dipstick test is done routinely. Unless the pregnant woman 
verbalises that she feels unwell or if she appears to be unwell, there is no other 
routine monitoring of heart rate; respiration; or temperature performed at the follow-up 
visits. One can argue that sufficient care is provided, but the concern would be that 
unidentified signs and symptoms might not be detected if routine monitoring of the 
heart rate is not performed and recorded during these follow-up visits.  
When the researcher asked about a protocol for the management and treatment of 
maternal tachycardia, the unit manager of the labour ward of Tygerberg Hospital 
revealed that there is no set protocol for the management and treatment of maternal 
tachycardia and patients are referred to this hospital according to the criteria of the 
BANC protocol (Lessing, 2011). When the same question was asked to a unit 
manager in at another hospital in the district, the response was also that there is no 
such set protocol for the management and treatment of maternal tachycardia, this 
person also referred to the BANC protocol (Anonym, 2011). 
2.6.2 Guidelines 
2.6.2.1 Perinatal Education Programme (PEP) 
The PEP manual serves as a reference for the BANC programme. This manual does 
not recommend that the routine monitoring of the pulse rate during pregnancy should 
be done, however, haemoglobin estimation, urine test for protein and glucose is done 
at every visit as routine side room examination (Woods, 2006).  
2.6.2.2 Guidelines for maternity care in South Africa 
The guidelines for maternity care in South Africa as issued by the Department of 
Health, (2007) is a comprehensive document which serves to guide healthcare 
workers providing obstetric and anesthetic services in clinics, community health 
centres and district hospitals. According to these guidelines all women with a history 
or symptoms and signs of heart disease, must be referred to a specialist clinic with 
expertise in the management of cardiac conditions in pregnancy, usually at level two 
or level three hospitals. This guideline manual has a less than two page explanation 
and description about cardiac disease in pregnancy consisting of symptoms and 
signs, antenatal care, management of labour, management of the puerperium, and 
management of pulmonary oedema (Department of Health, 2007:120). The signs and 
symptoms of possible cardiac disease are shortness of breath with mild effort; 
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shortness of breath when lying flat; haemoptysis; palpitations; chest pain; dizziness; 
rapid (equal or above 100 beats per minute) or irregular heart rate; and heart 
murmurs. Although it also states that auscultation of the heart is routinely carried out 
where possible, it is in question whether the auscultation is actually done, or the heart 
rate is routinely done.  
Although the previous version of the Guidelines for Maternity Care in South Africa 
(Department of Health, 2004:12) noted that health care workers at level one (clinics, 
community health centres, and day hospitals); level two and level three hospitals 
include midwives with PEP training, the new 2007 version (Department of Health, 
2007) makes no mention of the PEP manual and training.   
2.7 RESPONSIBILITIES OF MIDWIVES AT BANC CLINICS, MIDWIFE 
OBSTETRIC UNITS (MOU’S), AND HOSPITALS 
The latest Nursing Act No 33 of 2005; recently released SANC regulations; written 
guidelines and protocols as discussed, all relating to the midwives’ responsibilities.  
As discussed previously, the BANC clinic personnel are guided by BANC protocol and 
the PEP manual and it is also trusted that they are trained accordingly. The healthcare 
professionals should use the BANC protocol as a guide to screen for possible 
complications and thus refer the patient if necessary.  
BANC clinics and MOU’s deal primarily with lower risk cases than what would occur at 
a hospital, but emergencies occur. All midwifes and registered professional nurses 
working at BANC clinics, MOU’s and hospitals should be able to provide holistic 
maternal and neonatal care of good quality to the community.  
The emphasis of care rendered by midwives at a MOU, should fall on low-risk 
patients, thus bringing midwifery care closer to the pregnant women (Mabale, 
2003:23). This was the initial decision to move lower-risk maternity care closer to the 
people who need it, and to have this run by registered midwifes (Clow, 2011:1). 
2.7.1 BANC clinics 
In certain areas of the country, primary maternity services are provided as part of the 
National Health Plan (Abrahams et al., 2001:241). In these primary care settings 
pregnant patients are assessed at the BANC clinics on a follow-up basis and midwifes 
provide comprehensive services to women with normal uncomplicated pregnancies. 
Therefore, once a woman suspects pregnancy she starts attending the BANC clinic. 
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According to written protocol, the midwife is responsible to attend to all patients 
attending the clinic. The midwife should assess the normal growth of the pregnancy 
and screen for any problems arising during the course of pregnancy. Even though 
doctors usually visit the clinic once a week, women attending the services will only 
have a medical referral during pregnancy if they have a medical problem (Abrahams 
et al., 2001:241). In case of complications or problems, midwives assist and treat as 
far as possible within their scope of practice.  
Depending on the size of the clinic, there are usually two to three midwives and one 
nurse on duty. BANC clinics are open during the day from 07h00 to 16h00.  
2.7.2 Midwife obstetric units (MOU’s) 
Along with other responsibilities discussed in section 2.7.1, tasks of midwives range 
from coordinating patient care in the labour ward and postnatal section to the nursery. 
Other responsibilities the midwife is held responsible for is allocating staff for nursing 
activities. 
A MOU is also a primary care setting where midwives work as independent 
practitioners providing services in antenatal, intrapartum, postpartum and newborn 
care (Abrahams et al., 2001:241). The primary difference between a MOU and 
antenatal clinic as opposed to a hospital is the fact that midwives at a MOU and 
antenatal clinic carry out their work without a medical practitioner in the unit. Pregnant 
patients with problems go to the unit, are assessed by a midwife and from there, a 
decision is made by the midwife whether the patient needs admission or referral. 
Should the midwife need advice regarding patient care, midwives are responsible for 
following the referral criteria, by usually telephonically contacting the doctor at a 
nearby hospital and asking for advice and then following doctor’s instructions 
accordingly. 
Midwives working at MOU’s are responsible for monitoring the progression of labour, 
the fetal heart rate and delivery of normal vertex births. If any complication or 
emergency from admission should arise, these patients will and should, according to 
referral criteria, be referred to a nearby hospital. There are usually two to four 
midwives, one staff nurse and one to two nurses working per shift, depending on the 
size of the unit. These units work on a walk-in basis, thus patients cannot make any 
appointments, but booking at the nearest antenatal clinic is essential.  
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MOU’s are usually open 24 hours a day, 7 days a week, including public holidays. 
Therefore these midwives are expected to work night as well as day shifts. 
2.7.3 Hospitals 
Hospitals fall under the primary, secondary or tertiary level where midwives work 
interdependently with medical doctors and obstetricians in high-risk pregnancy cases 
(Abrahams et al., 2001:241). Secondary and tertiary level hospitals have intensive 
care facilities (Gandhi, Welz & Ronsmans, 2004:181). A level three hospital has all the 
emergency care facilities where a level two hospital may have a neonatal intensive 
care unit. There is usually at least a prenatal (or antenatal), labour, and postnatal 
ward, as well as a nursery at each hospital. Adding to the responsibility of midwives 
working at hospitals includes providing pre- and post-operative care, for patients 
requiring caesarian sections. The hospitals are also better equipped to manage 
complicated deliveries, therefore the midwives are also responsible for assisting the 
doctor in doing a forceps or suction delivery, or doing it herself in case of an 
emergency when there are no doctors available to do it, provided that she has the 
necessary training and has been found competent in doing these complicated 
deliveries. The size of the wards in the hospitals directly influence the number of 
midwives and other nursing staff on duty per shift.  
2.7.4 The role of the midwife regarding maternal tachycardia 
In the search to determine whether there is a set protocol for the management and 
treatment of maternal tachycardia, a midwife working at the high risk clinic at an 
academic hospital, admitted openly: “I have never received a patient that has been 
referred for maternal tachycardia and I have also never referred a patient myself that 
primarily presented with maternal tachycardia” (Bosman, 2011).  
Professor Theron, head of the department of obstetrics and gynaecology at 
Stellenbosch University concurs with Bosman’s (2011) statement. According to 
Theron (2011) maternal tachycardia in the prenatal period will be categorised into two 
groups, the first, namely tachycardia presenting as a secondary condition to a primary 
condition such as, anaemia and pyrexia. The second, where there is an underlying 
cardiac problem, such as arrhythmic disorders or a valve lesion. These patients would 
usually know that they have a problem or they will present with a symptom such as 
dyspnoea (shortness of breath), which should then serve as a reason for their referral. 
However, if tachycardia is the only reason for referral, Theron (2011) notes that this 
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would be extremely rare and that there is no specific guideline or protocol for the 
management and treatment of primary maternal tachycardia in the Cape Metropole.  
Murray and Huelsmann (2009:36) note that in sinus tachycardia, the nurse or midwife 
should perform an evaluation of the maternal temperature, pulse, blood pressure and 
respiratory rate before informing the physician. The nurse or midwife’s assessment 
should help the physician decide the best treatment plan, which should be directed at 
alleviating or treating the cause of the sinus tachycardia.  
2.7.5 Recordkeeping and reporting of abnormal observations  
The previously used antenatal card does not allow special recording of the maternal 
heart rate. Also, the new maternity case record does not have specific space for the 
recording of the maternal heart rate routinely with each antenatal visit, only on 
admission to hospital. Research done to strengthen the health care system in a rural 
area in Gauteng Provence in South Africa revealed poor record-keeping; inadequate 
supervision; poor levels of clinical knowledge; and under-utilization of MOU’s 
(Thomas, Jina, Tint & Fonn, 2007:38). 
In the research to strengthen the health care system in the mentioned rural area in 
South Africa, the researchers addressed topics such as programme-specific training 
and improving recordkeeping. They divided interventions into programmatic 
interventions with specific but narrow focus, such as mother-to-child transmission of 
HIV and system-level interventions, such as the health workers for change (Thomas et 
al., 2007:46). The health workers for change is a WHO-tested intervention developed 
in South Africa to improve the health system’s functioning and quality of interpersonal 
relations (between health workers as well as between health workers and patients) 
(Thomas et al., 2007:42). 
2.8 LIMITATIONS 
Although the PEP and BANC program are quite comprehensive in training, the 
researcher is of the opinion that there may be a shortfall in terms of the monitoring 
and the recording of the maternal heart rate. As previously discussed, the maternity 
case booklet now has got more space for the health care professional to write the 
findings of investigations.  
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2.9 SUMMARY 
In this chapter an overview was given on the physiological changes during pregnancy 
and contributing factors and causes of tachycardia were discussed. The role of the 
midwife within the boundaries of legislation, protocol and guidelines were discussed 
briefly. The role and responsibilities of the midwife in antenatal clinics, midwife 
obstetric units and hospitals were also discussed.   
This review of relevant literature, combined with the empirical findings of this study, 
will provide an understanding of the contributing factors and underlying medical 
conditions related to maternal tachycardia and may indicate changes to the protocol of 
antenatal care as used at present by health care facilities. By focusing on the 
prevalence of maternal tachycardia observed during prenatal visits at the Safe 
Passage Study, this study intends to bring attention to the impact a raised maternal 
heart rate has to the wellbeing of the mother and her unborn fetus. 
The methodology to study the prevalence of maternal tachycardia during late 
pregnancy will be discussed in detail in Chapter 3. 
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CHAPTER 3: RESEARCH METHODOLOGY 
3.1 INTRODUCTION 
In chapter 2, relevant literature relating to the topic of research was reviewed. 
Concepts and variables that influenced the development of the data collection 
instrument were also introduced. This chapter entails the research methodology’s 
different phases in depth to determine the prevalence of maternal tachycardia during 
late pregnancy. Mouton (2009:55) explains that research methodology consists of the 
systematic, methodological and accurate execution of the research design. 
3.2 RESEARCH METHODOLOGY 
3.2.1 Research approach and design 
De Vos et al. (2009:75) summarises the purpose of a quantitative research approach 
as the testing of predictive and cause-effect hypotheses about social reality. A 
quantitative research approach was best suited for this study as the prevalence of 
maternal tachycardia during late pregnancy and its association with anaemia and 
cardiac lesions was determined. These findings were compared to that of a control 
group of pregnant women who had normal heart rates during late pregnancy.  
This study had a case-control retrospective study design within a prospective study, 
because the analysis of already collected data was conducted. According to Mouton 
(2009:55), a research design is a plan or a blueprint of how one intends to conduct 
his/her research. Thus, a combination of explorative and correlational research design 
best suited this research study. A correlational design is defined as a study design for 
examining the relationships between or among two or more variables in a single 
group, which can occur at several levels (Burns & Grove, 2007:535). Elahi and 
Dehdashti (2011:1) describes that the most important purpose of an exploratory 
research design is to formulate hypotheses regarding potential problems and 
opportunities present in the decision situation. The abovementioned authors further 
explain that this type of research can be applied when, for example, the research 
objectives are identifying problems (Elahi & Dehdashti, 2011:1). The researcher chose 
a combination of these designs to maximise the possibility of obtaining valid answers 
to the research hypotheses. De Vos et al. (2009:106) explain the need for an 
exploratory study could arise in order to get acquainted with a situation so as to 
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formulate a problem or develop a hypothesis. Therefore, the researcher decided that a 
quantitative research approach best suited the nature of this retrospective study. 
Mouton (2009:51) refers to the unit of analysis as the “what, object, phenomenon, 
entity process or event” that forms the main focus of which the researcher is 
interested in studying. In this study, pregnant women recruited for the Safe Passage 
Study that had a Monica AN24™ recording in late pregnancy at the Safe Passage 
Study, Tygerberg Hospital were the unit of analysis. Furthermore these recordings 
were analysed only to identify those pregnant women who presented with tachycardia 
to form the case group. In addition, these cases were compared with a control group 
of women with normal maternal heart rates.  
3.2.2 Target population and sampling  
The term target population is stated by Burns and Grove (2007:324) as “the entire set 
of persons (or elements) who (or that) meet the sampling criteria. In more detail, De 
Vos et al. (2009:194) describe target population as: “the totality of persons, events, 
organisation units, case records or other sampling units with which the research 
problem is concerned”. The population targeted for data collection in this ancillary 
study included all the participants that were recruited for the main study phase II, as 
indicated by the Manual of procedures (2011:1), between 20 July 2009 and 4 July 
2011. By the time the researcher completed the selection of participants, the majority 
of participants have had already delivered their babies and had been discharged from 
hospital. The statistics of the Safe Passage Study, Tygerberg Hospital revealed a total 
of 2097 participants that were recruited during that time span. To determine the 
overall prevalence rate of maternal tachycardia, as observed during the routine 
recordings between 34 and 38 weeks gestation, a total of 1431 Monica AN24™ 
recordings at this specific gestation were examined. The target population for this 
study is therefore 1431 participants (N=1431) from whom the participants who had 
tachycardia and the appropriate controls were selected. Of the total 2097 recruited 
participants recorded Monica AN24™ data, some data was lost and other participants 
had not yet had a Monica AN24™ recording at 34 to 38 weeks gestation but this 
would not have influenced the prevalence rate of tachycardia. 
Seaberg, as cited in De Vos et al. (2009:194), describes a sample as a small set of 
the total set of objects, events or persons which together comprises the subjects of 
our study.  
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A non-probability, purposive sample (n=102) was used to select the participants 
presenting with maternal tachycardia to form the case group. A control group (n=102) 
was also selected by means of a non-probability, purposive sample as indicated in 
figure 3.1. Each control group participant was selected after each case of maternal 
tachycardia was identified in the case group. These participants were then selected in 
a consecutive manner following the selection of each participant in the case group 
(n=102). The reason for selecting the control group participants consecutively was to 
exclude possible environmental temperature changes that might have had an 
influence on heart rate as mentioned earlier in chapter one. 
Purposive sampling is defined as the judgemental or selective sampling method that 
involves the conscious selection by the researcher of certain subjects or elements to 
be included in a study (Burns & Grove, 2007:344). Polit and Beck (2010:309) refers to 
non-probability sampling as the selection of elements by non-random methods, in 
other words the researcher would select a sample purposively or by judgement. The 
authors further explain that by using purposive sampling, the researcher purposively 
selects subjects who are judged to be typical of the population or typically 
knowledgeable about the issues under study (Polit & Beck, 2010:312).  
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Figure 3.1: Target population and sampling outlay for this study 
A statistician from Stellenbosch University’s Centre for Statistical Consultation was 
consulted to determine the sample size for this study. Referring to section 1.2.2 in 
Chapter one, the sample size was calculated based on Stoker’s table (1985) (cited in 
De Vos, 2001:192), the researcher drew just over 14% sample (thus 14.25%) for both 
the case group (n=102), and the control group (n=102) (N=1431 X 14.25% = 204 ÷ 2 
= n=102). In addition, the accuracy of the proportions that are estimated from the 
sample increases marginally with a sample of more than 200 (Clopper & Pearson, 
1934:404). Therefore it was decided that a total sample size of approximately 204 
(n=204) was consequently efficient. The reason for this particularly outdated reference 
used was that the use of the binomial distribution has not changed since 1934 and is 
still used today to determine the sample size. For this reason, the researcher made 
the decision of the efficiency of the sample size of 204 (n=204). 
3.2.3 Inclusion and exclusion criteria 
Due to the fact that this is an ancillary study, the researcher only focused on the 34 to 
38 weeks gestation period. There were certain inclusion and exclusion criteria for 
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participation in the main study, as explained in the Manual of Procedures, Version 3.1 
(Sharepoint DM-Stat, 2011:76). The criteria listed below were modified from the 
criteria listed for the main study, except for the last two inclusion criteria, and 
exclusion criteria bullet number four, as these were only applicable to this study. 
3.2.3.1 Inclusion criteria 
To be included in this study, participants: 
• had to be recruited between 20 July 2009 and 4 July 2011; 
• had to have had a Monica AN24™ recording at 34 to 38 weeks gestation; 
• had to have at least 20 minutes of rest before recording was started; and  
• had to have a recording done whilst lying at a 15˚ angle left or right lateral tilt. 
3.2.3.2 Exclusion criteria 
Participants were excluded from this study if: 
• they were recruited before 20 July 2009 and after 4 July 2011; 
• any external factors were present that may have caused maternal tachycardia, 
for example latent labour; and smoking in last 20 minutes before the recording 
commenced; and  
• they exercised or ate 30 minutes before the recording commenced. 
The exclusion criteria in the last two listed bullets were decided upon for the reason to 
exclude any possible cause of maternal tachycardia. Therefore the Monica AN24™ 
recordings were carefully selected for inclusion in the study. 
3.2.4 Data collection instrument 
For this study a computerised Ms Excel spreadsheet was the data collection 
instrument. The researcher compiled this spreadsheet to collect the data needed for 
this sub-study. The researcher decided on a spreadsheet as the data collection 
instrument because data of the Monica AN24™ has already been done by the main 
study. According to the design of this study, other appropriate data needed for 
collection for this study could only be collected from hospital records of the 
participants that were selected for this sub-study. Therefore a data collection 
instrument to best collect all the appropriate information needed for this study was 
thus a computerized Ms Excel spreadsheet. 
The items on this spreadsheet were based on all the objectives and reviewed 
literature. The spreadsheet was designed to divide the items into nine different 
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sections. Section one required the participants’ unique study numbers and under 
which group they fall, for example, case or control. Section two required the 
participants’ demographic data such as, maternal age, race, gravidity, parity, 
pregnancy losses, height and weight. The Monica AN24™ data of each participant 
was collected in section 3. Information regarding smoking was collected in the fourth 
section. Maternal heart rate recorded during the antenatal period was recorded in 
section five. Information regarding maternal haemoglobin values was collected in the 
sixth section. A summary of maternal and neonatal outcomes was collected in section 
seven and eight. In section nine a summary of the Apgar scores was collected. 
The spreadsheet included statements that required a “yes” or “no” answer and some 
requiring close-ended answers that were selected from specified response options in 
a dropdown menu on the spreadsheet. No open-ended answers were included in this 
spreadsheet. 
3.2.5 Pilot study  
A pilot study was conducted by means of pre-testing the data collection instrument 
and analysing the data that was generated before commencement of the main study 
in order to “...bring possible deficiencies to the fore timeously” (De Vos et al., 
2009:82). A pilot study is defined as a mini-study, small-scale version or trial run done 
in preparation for the main study (Polit & Beck, 2010:536). By pre-testing the data 
collection instrument, one typically tries out the instrument on a smaller number of 
participants having similar characteristics to those of the target group (De Vos et al., 
2009:206).  
The pilot study was done by means of selecting (sampling) the participants in the 
same manner as to which the main study were selected, namely purposively. This 
ensured that both case and control groups were included in the pilot study and not just 
in the main study. The participants involved in the pilot study were selected out of the 
same population as the main study.  
As the pilot study usually forms a 5% to 10% sample of the selected participants, the 
researcher decided on an initial 5% (n=12) sample size for the pilot study. A total of 16 
participants were finally included as no further changes needed to be made to the 
concept data collection instrument. The pilot study took place during the 1st and 31st of 
July 2011. 
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Changes to section five, maternal heart rate recorded during the antenatal period was 
made. The selection option on some dropdown boxes for example, “pre-existing 
cardiac conditions” were adjusted to better suit the main study. After collection of the 
16 participants’ data for the pilot study and no more modifications were made to the 
concept data collection instrument, the data was sent to a statistician to determine if 
the data was free of any errors and could also be analysed statistically.  
3.2.6 Reliability and validity  
The reliability of a measurement procedure as referred to by De Vos et al. (2009:162) 
is the stability or consistency of the measurement. Reliability for this study was 
ensured by means of the conduction of a pilot study. The data collection instrument 
was pre-tested under the exact same conditions as the actual study. As mentioned 
under the section 3.2.5, 16 participants’ data were collected for the purpose of the 
pilot study. Changes were then made to improve the data collection instrument. Thus 
the instrument’s ability to “yield consistent numerical results each time it is applied” 
(De Vos et al., 2009:163) ensured that the instrument was reliable. 
The validity of an instrument is measured on a continuum and is defined as the 
determination of how well the instrument reflects the abstract concept being examined 
(Burns & Grove, 2007:365). Face validity refers to the extent to which an instrument 
looks as though it is measuring what it professes or appears to measure (Polit & Beck, 
2010:554). In this study, subjective judgements regarding the degree to which the 
instrument appeared to measure the relevant variables, was made by experts in 
research methodology.  
De Vos et al. (2009:162) explains that construct validity is concerned with the meaning 
of the instrument and involves not only the validation of the instrument itself but also 
the theory underlying it. The authors point out that the meaning of the construct must 
be understood as well as the proposition the theory makes about the relationships 
between this and other constructs must be identified to be able to establish construct 
validity (De Vos et al., 2009:162).  
Content-related validity is referred to by Burns and Grove (2007:535) as the extent to 
which the method of measurement includes all the major elements relevant to the 
construct being measured, thus what it is expected to measure. The content, 
feasibility and advice regarding the description of the study and comparison of the 
findings between the case group and control group was discussed with a statistician 
from Stellenbosch University’s Statistical Department. The opinions of experts 
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provided validation to the instrument and assured the content and construct validity for 
this study.  
As the data collection instrument was designed, it was reshaped until there was surety 
that the data collected will measure what it is expected to measure. Also, the variables 
in the data collection instrument were based on the objectives that were set for this 
study. A statistician from Stellenbosch University’s Centre for Statistical Consultation 
was consulted to check whether all the variables could be analysed statistically.   
3.2.7 Data collection 
Ethical approval was obtained from the Health Research Ethics Committee of 
Stellenbosch University’s Division of Research Development and Support on the 3rd of 
June 2011. Data was collected by the researcher herself from the 1st of August 2011 
and completed by the 20th of November 2011. The data collection instrument was a 
computerised Ms Excel spreadsheet, designed by the researcher herself. The data 
was collected in the researcher’s own free time which was beneficial as she collected 
data as it suited her. 
Unfortunately, to ensure that all the selected participants had delivered their babies 
and were discharged from hospital, data collection took longer than what was 
planned. Data collection took place at Tygerberg Hospital at the Safe Passage Study’s 
secured office. The process continued until the sample reached the designated size, 
which was a total of 204 (n=204) participants that were selected for this study, 
respectively the case group (n=102) and the control group (n=102).   
Each participant’s data collected from the Monica AN24™ device were connected to a 
laptop, for downloading of the raw data. The integrated DK 1.2b software programme 
that was developed by the manufacturers examined the raw data. From this analysis, 
the researcher identified relevant candidates based on the selection criteria. Once 
these 204 candidates were identified, the DK 1.2b software data of each selected 
participant was revisited to collect more information.  
Data was collected from the Monica AN24™ recordings as well as copied hospital 
records of each participant. Files of raw maternal heart rate data were obtained at the 
Safe Passage Study’s secured office from the laptop where the Monica AN24™ 
recordings are downloaded after each recording. The files of raw data of each 
participant were copied to an external hard drive for later analyses. Copied hospital 
records of each participant were obtained from the same office. Section two of the 
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spreadsheet, demographic variables was collected from the copied hospital records. 
Section four to nine, data of maternal heart rate recording during antenatal visits, 
information regarding haemoglobin values, a summary of maternal and neonatal 
outcome and Apgar scores was obtained from the copied hospital records. This data 
was collected under section two of the spreadsheet. The researcher analysed the 
Monica AN24™ recordings and collected data such as maternal heart rate, fetal heart 
rate, the success of the recording and the duration and date of the recording. 
3.2.8 Data analysis 
Due to the fact that this is a quantitative study and that data was collected on an 
Microsoft Excel spreadsheet, the capturing of data was also done on Microsoft Excel. 
The DK 1.5b programme (Monica AN24, 2008:9) was used to analyse the raw data 
and extract the continuous maternal heart rate from the collected raw maternal ECG 
signals. 
A statistician from Stellenbosch University’s Centre for Statistical Consultation was 
consulted to perform the statistical analyses from the data collection instrument. The 
programme STATISTICA version 9 (StatSoft Inc., 2009) was used to analyse the data. 
The distribution of variables was presented with categorised histograms and 
frequency tables.  
Chi-square statistics were used to analyse nominal data to determine significant 
differences between observed frequencies within data and frequencies that were 
expected (Burns & Grove, 2007:420). The relationships between continuous response 
variables and nominal input variables were analysed using appropriate analysis of 
variance (ANOVA). Univariate analysis is used to establish whether associations 
existed between cases and controls and the factors in the objectives such as maternal 
haemoglobin; anaemia; presence or absence of cardiac lesions or disease; presence 
or absence of infection; gestational age at delivery and birth weight was undertaken.  
3.3 SUMMARY 
The methodology used for this research project is discussed in detail in this chapter. 
The research approach and design; target population and sampling; inclusion and 
exclusion criteria; data collection instrument; pilot study; reliability and validity; data 
collection and a summary of the data analysis techniques were reflected on in this 
chapter.  
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In chapter four the analysis and interpretation of the results will be provided and 
discussed in detail. 
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CHAPTER 4: DATA ANALYSIS AND RESULTS 
4.1 INTRODUCTION 
The purpose of this study was to determine the prevalence of maternal tachycardia 
during late pregnancy and its association with anaemia, major cardiac disease and/or 
complications and adverse maternal and perinatal outcome. This study was 
quantitative in nature with a case-control retrospective study design. The researcher 
sampled 102 cases for the case group and 102 cases for the control group from a 
total of 1431 Monica AN24™ recordings that were examined. A computerised 
Microsoft Excel spreadsheet was used as the data collection instrument and the 
quantitative data was collected on nominal and continuous level.  
The researcher looked at each individual variable and determined applicable 
outcomes which would yield the data relevant to the study. All data collected for this 
study were collected and entered on the computerised spreadsheet by the researcher 
herself. This approach required the researcher to read through every participant’s 
copied hospital records to find the necessary data needed for collection.  
As discussed in section 2.4 in chapter 1, all statements of the data collection 
instrument required closed-ended answers selected from specified response options 
in a drop down menu on the spreadsheet. There were no statements requiring open-
ended answers. Data for some participants were lost, in which case a blank space 
was left on the spreadsheet where those entries had to be made. The results of each 
item were displayed in either histograms or frequency tables in this chapter and after 
each section a conclusive summary was made.  
4.2 ANALYSIS OF THE QUANTITATIVE DATA 
Mouton (2009:108) explains that analysis involves breaking the data into manageable 
themes, patterns, trends and relationships. The author further describes the aim of 
analysis is to understand the various constitutive elements of one’s data through an 
inspection of the relationship between concepts, constructs or variables. Mouton 
(2009:108) furthermore states that analysis is also done “to see whether there are any 
patterns or trends that can be identified or isolated, or to establish themes in the data”.  
Quantitative data was generated and analyzed to provide information on the 
prevalence of maternal tachycardia during late pregnancy and its association with 
anaemia, major cardiac disease and/or complications and adverse maternal and 
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perinatal outcome. As mentioned previously, the raw quantitative data was captured 
and analysed using Microsoft Excel and STATISTICA version 9 software programmes 
(StatSoft., 2009). The percentages were rounded off to the first decimal to simplify the 
discussion in the text. Descriptive statistics were used to organise the data and 
describe the variables for this study (see par. 3.2.8). 
The reader may find that some of the histograms do not total to 100%, which occur, 
according to the statistician who did the analysis of the data, due to rounding off of 
percentages. This is seen in many studies and is universally accepted. 
4.2.1 Descriptive analysis of all the variables 
The results for this study were presented in descriptive frequency tables and 
histograms, thereafter discussed sequentially under the following sections: Section A: 
Maternal demographic data; Section B: Monica AN24™ heart rate; Section C: 
Maternal heart rate recorded during antenatal period; Section D: Haemoglobin (Hb) 
value; Section E: Maternal outcome; Section F: Neonatal outcome; and Section G: 
Apgar score.  
Table 4.1: Descriptive statistics of case group 
Variable Valid 
N 
Mean Median Minimum Maximum Standard 
deviation 
1. Maternal age (years) 102 22.9 22.0 16.0 43.0 5.7 
3. Gravidity 102 1.8 1.0 1.0 6.0 1.0 
4. Parity 102 0.7 0.0 0.0 5.0 0.9 
6. Height (meter) 100 1.6 1.6 1.5 1.7 0.1 
7. Weight (kilogram) 100 62.2 59.5 41.2 109 13.7 
10. MHR success rate  
     (%) 
102 99.9 100.0 97.1 100.0 0.4 
11. MHR duration of  
     recording (minutes) 
102 53.7 53.0 30.0 100.0 8.6 
15. Number of ANC  
     visits 
93 5.9 6.0 2.0 13.0 1.8 
16. Frequency of MHR  
      recordings 
93 11.7 8.0 1.0 69.0 10.7 
17. MHRRA booking 101 0.0 0.0 0.0 0.0 0.0 
18. MHRRA other ANC  
     visits 
101 0.1 0.0 0.0 4.0 0.6 
19. MHRRA walk-in  
      visits 
94 0.6 0.0 0.0 17.0 2.1 
20. MHRRA referrals 93 1.3 0.0 0.0 15.0 2.4 
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Table 4.1 continued… 
Variable Valid 
N 
Mean Median Minimum Maximum Standard 
deviation 
21. MHRRA labour 93 4.6 3.0 0.0 22.0 4.3 
22. MHRRA post- 
     delivery 
93 5.1 3.0 0.0 52.0 7.4 
23. Hb at booking (g/dL) 89 12.0 12.0 8.5 16.5 1.3 
24. Hb at 28 – 38 weeks  
     (g/dL) 
85 10.7 10.5 7.0 14.0 1.3 
25. Hb at delivery (g/dL) 46 10.5 10.4 7.1 15.5 1.7 
26. Hb frequency 91 2.9 3.0 0.0 6.0 1.1 
35. Birth weight (gram) 102 3226 3220 2250 4905 441 
36. GA at delivery  
     (weeks) 
102 39.2 39.0 36.0 42.0 1.3 
39. Apgar at 1 minute 102 8.8 9.0 5.0 10.0 0.8 
40. Apgar at 5 minutes 102 9.8 10.0 6.0 10.0 0.6 
41. Apgar at 10 minutes 52 9.9 10.0 8.0 10.0 0.3 
*MHR - Monica AN24™ heart rate    
*ANC  - Antenatal clinic 
*MHRRA - Maternal heart rate recorded antenatally 
*Hb – Haemoglobin  
*GA - Gestational age  
 
Table 4.2: Descriptive statistics of control group 
Variable Valid 
N 
Mean Median Minimum Maximum Standard 
deviation 
1. Maternal age (years) 102 24.4 23.5 16.0 41.0 5.8 
3. Gravidity 102 2.2 2.0 1.0 5.0 1.2 
4. Parity 102 1.1 1.0 0.0 5.0 1.2 
6. Height (meter) 100 1.6 1.6 1.4 1.8 0.1 
7. Weight (kilogram) 101 62.3 60.0 40.0 101.5 14.8 
10. MHR success rate  
      (%) 
102 99.9 100.0 97.9 100.0 0.3 
11. MHR duration of  
      recording (minutes) 
102 55.2 55.5 20.0 93.0 9.0 
15. Number of ANC  
      visits 
99 5.4 5.0 1.0 13.0 2.3 
16. Frequency of MHR  
      recordings 
99 9.5 6.0 1.0 65.0 9.3 
17. MHRRA booking 102 0.0 0.0 0.0 1.0 0.1 
18. MHRRA other ANC  
      visits 
102 0.1 0.0 0.0 12.0 1.2 
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Table 4.2 continued… 
Variable Valid 
N 
Mean Median Minimum Maximum Standard 
deviation 
19. MHRRA walk-in  
      visits 
100 0.3 0.0 0.0 4.0 0.6 
20. MHRRA referrals 99 0.8 0.0 0.0 22.0 2.4 
21. MHRRA labour 99 3.6 2.0 0.0 23.0 5.1 
22. MHRRA post- 
     delivery 
99 4.6 3.0 0.0 26.0 5.3 
23. Hb at booking (g/dL) 93 12.0 11.9 8.1 15.3 1.3 
24. Hb at 28 – 38 weeks  
     (g/dL) 
68 10.8 11.0 8.0 14.0 1.1 
25. Hb at delivery (g/dL) 31 11.0 11.1 6.8 14.7 1.9 
26. Hb frequency 95 2.5 3.0 0.0 5.0 1.1 
35. Birth weight (gram) 102 3032 3050 1500 4400 604 
36. GA at delivery  
      (weeks) 
102 38.9 39.0 34.0 42.0 1.7 
39. Apgar at 1 minute 97 8.7 9.0 2.0 9.0 1.0 
40. Apgar at 5 minutes 97 9.8 10.0 2.0 10.0 0.9 
41. Apgar at 10 minutes 49 9.8 10.0 1.0 10.0 1.3 
*MHR - Monica AN24™ heart rate 
*ANC - Antenatal clinic 
*MHRRA - Maternal heart rate recorded antenatally 
*Hb - Haemoglobin 
*GA - Gestational age 
4.2.2 Section A: Maternal demographic data 
In this section the information relating to the study sample in terms of the variables: 
maternal age; race; gravidity; parity; height; and weight were obtained. All the data of 
the various items was collected unless stated otherwise in the discussion of each.  
4.2.2.1 Maternal age 
Data of the maternal age included the case group (n=102) and the control group 
(n=102). Table 4.1 displays the basic descriptive statistics of the case group and table 
4.2 that of the control group. In the case group the maternal ages ranged from 16 to 
43 years with a mean of 22.9 years (Table 4.1). Forty point two percent (40.2%) of 
participants were between 15 and 20 years old (Figure 4.1). In the control group the 
ages ranged from 16 to 41 years with a mean of 24.4 years (Table 4.2) and 14.7% 
were between 16 and 18 and 20 to 22 years old, therefore a bimodal distribution 
(Figure 4.2). 
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A box plot of the maternal age of both groups is displayed in figure 4.3. The minimum 
age was 16 years and the maximum age was 43 years for the case group. The 
minimum age was 16 years and the maximum age was 41 years for the control group. 
The interquartile range which is the middle half of the data set for the case group is 
about 18 to 25 and for the control group 20 to 25 years. For both the case and the 
control groups the age distribution of most of the participants were on the low end of 
the scale, thus the distribution is skewed towards lower ages. 
According to the analyses of variance (Table 4.3) the mean maternal ages did not 
differ significantly between the two groups. However the Mann-Whitney U Test, 
showed a significant difference (p < 0.05) between the two groups (Table 4.4). 
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Figure 4.1: Maternal age of case group 
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Figure 4.2: Maternal age of control group 
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Figure 4.3: Box plot of maternal age of both groups 
 
Table 4.3: Analysis of variance of variables 
Variable SS 
Effect 
df 
Effect 
MS 
Effect 
SS 
Error 
df 
Error 
MS 
Error 
F p 
1. Maternal age  
    (years) 
109 1 109 6634 202 32.8 3.3 0.07 
3. Gravity 7 1 7 241 202 1.2 6.2 0.01 
4. Parity 10 1 10 222 202 1.1 9.0 0.00 
6. Height (meter) 0 1 0 1 198 0.0 0.0 0.94 
7. Weight (kilogram) 1 1 1 40529 199 203.7 0.0 0.94 
10. MHR success  
      rate (%) 
0 1 0 23 202 0.1 0.0 0.85 
11. MHR duration of  
     recording  
     (minutes) 
118 1 118 15726 202 77.9 1.5 0.22 
15. Number of ANC  
      visits 
13 1 13 786 190 4.1 3.2 0.07 
16. Frequency of  
      MHR recordings 
228 1 228 19083 190 100.4 2.3 0.13 
17. MHRRA booking 0 1 0 1 201 0.0 1.0 0.32 
18. MHRRA other  
     ANC visits 
0 1 0 184 201 0.9 0.0 0.93 
19. MHRRA walk-in  
      visits 
6 1 6 443 192 2.3 2.4 0.12 
20. MHRRA referrals 12 1 12 1127 190 5.9 2.0 0.16 
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Table 4.3 continued… 
Variable SS 
Effect 
df 
Effect 
MS 
Effect 
SS 
Error 
df 
Error 
MS 
Error 
F p 
21. MHRRA labour 47 1 47 4236 190 22.3 2.1 0.15 
22. MHRRA post  
     delivery 
10 1 10 7745 190 40.8 0.2 0.63 
23. Hb booking  
     (g/dL) 
0 1 0 307 180 1.7 0.2 0.74 
24. Hb 28 – 38  
     weeks (g/dL) 
0 1 0 219 151 1.5 0.3 0.57 
25. Hb delivery  
     (g/dL) 
5 1 5 238 75 3.2 1.5 0.23 
26. Hb frequency  7 1 7 224 184 1.2 6.0 0.02 
35. Neonatal birth  
      weight 
19082
00 
1 1908
200 
56466
541 
202 27953
7 
6.9 0.01 
36. GA at delivery  
     weeks 
5 1 5 484 202 2.4 2.1 0.15 
39. Apgar at 1  
     minute 
0 1 0 152 197 0.8 0.3 0.56 
40. Apgar 5 minute 0 1 0 107 197 0.5 0.0 0.85 
41. Apgar 10  
      minutes 
0 1 0 86 98 0.9 0.5 0.50 
*MHR - Monica AN24™ heart rate 
*ANC  - Antenatal clinic 
*MHRRA - Maternal heart rate recorded antenatal 
*Hb - Haemoglobin 
*GA - Gestational age 
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Table 4.4: Mann-Whitney U Test 
Variable Rank 
Sum 
Case 
Rank 
Sum 
Control 
U Z p-  
value 
Z 
adjusted 
p-
value 
Valid 
N 
Case 
Valid N 
Control 
2*1 
sided 
exact 
p 
1. Maternal age  
   (years) 
9578.0 11332.0 4325.0 -2.08 0.04 -2.08 0.04 102 102  
3. Gravidity 9445.5 11464.5 4192.5 -2.39 0.02 -2.54 0.01 102 102  
4. Parity 9345.5 11564.5 4092.5 -2.63 0.01 -2.82 0.00 102 102  
6. Height (meter) 10071.0 10029.0 4979.0 0.05 1.00 0.05 0.96 100 100  
7. Weight  
   (kilogram) 
10142.0 10159.0 5008.0 0.10 0.92 0.10 0.92 100 101  
10. MHR  
     success rate  
     (%) 
10803.5 10106.5 4853.5 0.83 0.41 1.01 0.31 102 102  
11. MHR  
      duration  
      recording  
      (minutes)  
9189.0 11721.0 3936.0 -3.00 0.00 -3.01 0.00 102 102  
15. Number of  
     ANC visits 
9659.5 8868.5 3918.5 1.78 0.08 1.81 0.07 93 99  
16. Frequency of  
     MHR  
     recordings 
9726.5 8801.5 3851.5 1.95 0.05 1.96 0.05 93 99  
17. MHRRA  
      booking 
10251.5 10454.5 5100.5 -0.12 0.90 -0.99 0.32 101 102  
18. MHRRA  
      other ANC  
      visits 
10504.0 10202.0 4949.0 0.48 0.63 1.64 0.10 101 102  
19. MHRRA  
      walk-in visits 
9438.0 9477.0 4427.0 0.70 0.49 0.90 0.37 94 100  
20. MHRRA  
      referrals 
9636.5 8891.5 3941.5 1.72 0.09 1.98 0.05 93 99  
21. MHRRA  
      labour 
10154.0 8374.0 3424.0 3.06 0.00 3.10 0.00 93 99  
22. MHRRA  
      post-delivery 
8981.5 9546.5 4596.5 0.02 0.99 0.02 0.99 93 99  
23. Hb booking  
     (g/dL) 
8053.5 8599.5 4048.5 -0.25 0.80 -0.25 0.80 89 93  
24. Hb 28-38  
      weeks (g/dL) 
6397.5 5383.5 2742.5 -0.54 0.59 -0.55 0.59 85 68  
25. Hb delivery  
      (g/dL) 
1654.5 1348.5 573.5 -1.44 0.15 -1.44 0.15 46 31 0.15 
26. Hb frequency 9235.5 8155.5 3595.5 1.98 0.05 2.07 0.04 91 95  
35. Birth weight 11452 9458.5 4205.5 2.36 0.02 2.36 0.02 102 102  
36. GA at  
      delivery  
      weeks 
10912.5 9997.5 4744.5 1.08 0.28 1.11 0.27 102 102  
39. Apgar 1 min 10357.0 9543.0 4790.0 0.39 0.70 0.63 0.53 102 97  
40. Apgar 5 min 9979.0 9921.0 4726.0 -0.54 0.59 -0.94 0.35 102 97  
41. Apgar 10 min 2554.0 2496.0 1228.0 -0.14 0.88 -0.38 0.70 51 49 0.89 
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4.2.2.2 Race  
The discussion of the maternal race included both groups (n=204), namely the control 
group (n=102) as well as the case group (n=102). All the participants were coloured 
people (n=204 or 100%). 
4.2.2.3 Gravidity 
The discussion of the maternal gravidity included both groups (n=204), namely the 
control group (n=102) and the case group (n=102), as well as the two groups 
individually. The gravidity for both groups ranged from gravida one to gravida six. The 
mean gravidity for the case group was 1.8 (Table 4.1). The mean gravidity for the 
control group was 2.2 (Table 4.2). The median gravidity for the case and control 
groups was 1 and 2 respectively (Table 4.1 and 4.2). Therefore, the majority of 
participants in the case group were gravida one and the majority of participants in the 
control group were gravida two. The majority of all the participants were gravida one 
(n=90 or 44.1%) (Table 4.5). From figure 4.4, it is clear that the majority of participants 
in the case group was gravida one (n=52 or 51.0%), which is 14% more, comparing to 
the majority of the control group, also gravida one (n=38 or 37.0%) (see figure 4.5). 
According to table 4.3, the analyses of variance and also the Mann-Whitney U Test 
(Table 4.4) the gravidity showed a significant difference (p < 0.05) between the two 
groups.  
Table 4.5: Maternal gravidity of both groups 
Gravidity Frequency 
(f) 
Percentage 
(%) 
1 90 44.1 
2 58 28.4 
3 34 16.7 
4 16 7.8 
5 5 2.5 
6 1 0.5 
Total n=204 100 
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Figure 4.4: Maternal gravidity of case group 
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Figure 4.5: Maternal gravidity of control group 
4.2.2.4 Parity 
The discussion of the maternal parity included each individual group, namely the 
control group (n=102) and the case group (n=102). The parity for each group ranged 
from parity zero to parity five. The mean parity for the case group was 0.7 (Table 4.1) 
and the mean parity for the control group was 1.1 (Table 4.2). As indicated in figure 
4.6 the majority of the participants in the case group were nulliparous (n=56 or 
55.0%). The majority of the participants in the control group as indicated in figure 4.7 
were also nulliparous (n=40 or 39.0%) however, fewer than the case group. According 
to table 4.3 the analyses of variance and the Mann-Whitney U Test (Table 4.4) parity 
showed a significant difference (p < 0.05) between the two groups. 
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Figure 4.6: Maternal parity of case group 
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Figure 4.7: Maternal parity of control group 
4.2.2.5 Pregnancy losses  
The discussion of miscarriage included both groups (n=204), namely the control group 
(n=102) as well as the case group (n=102). As indicated in table 4.6 the cumulative 
count of the category of pregnancy losses was 18, of which the majority have had one 
previous miscarriage (n=10 or 55.5%). The description of each acronym is next to the 
acronym in the Table 4.6.  
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Table 4.6: Pregnancy losses of both groups 
Category Frequency 
(f) 
Percentage 
(%) 
MISC1 (first miscarriage) 10 55.5 
ID (infant death) 2 11.1 
AB1 (first abortion) 3 16.6 
AB2 (second abortion) 1 5.6 
IUD (intra uterine death) 1 5.6 
MISC2 (second miscarriage) 1 5.6 
Total n=18 100 
4.2.2.6 Height 
The data of four (n=4) of the participants were not available, two (n=2) from the control 
group and two (n=2) from the case group, as it was not entered in the copied records. 
The discussion of the maternal height included the individual groups namely the 
control group (n=100) and case group (n=100). Although the height of the participants 
was entered individually in Excel, the analysis thereof was grouped in height ranges. 
As indicated in figure 4.8 the most frequent height of the participants in the case group 
was in the range of 1.58 to 1.6 meters (n=13 or 13.0%). As indicated in figure 4.9, the 
most frequent height of the participants in the control group was in the range of 1.55 to 
1.60 meters (n=32 or 32.0%). According to the analyses of variance (Table 4.3) and 
the Mann-Whitney U Test (Table 4.4), the height showed no significant difference (p < 
0.05) between the two groups. 
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Figure 4.8: Maternal height of case group 
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Figure 4.9: Maternal height of control group 
4.2.2.7 Weight 
The data of three (n=3) of the participants were not available, as it was not entered in 
the copied records. Although the weight of the participants was entered individually in 
Excel, the analyses thereof were grouped in weight ranges. As indicated in figure 
4.10, the most frequent weight of the participants in the case group was 51 to 60 
kilograms (34.0%). As indicated in figure 4.11 the most frequent weight of the 
participants in the control group was 50 to 54 kilograms (16.0%). According the 
analyses of variance (Table 4.3) and the Mann-Whitney U Test (table 4.4), the weight 
showed no significant difference (p < 0.05) between the two groups. 
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Figure 4.10: Maternal weight of case group 
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Figure 4.11: Maternal weight of control group 
It is clear from the findings discussed in the above section that the mean age for the 
case group was 22.9 years and the control group was 24.4 years (Tables 4.1 and 4.2). 
All the participants were coloured people. The majority of participants of both groups 
were gravida one and nulliparous. There was a cumulative count of 18 (n=18) 
pregnancy losses throughout this study. The most frequent height of the participants 
was in the range of 1.58 to 1.60 meters (Figure 4.8) in the case group and 1.55 to 
1.60 meters in control group (Figure 4.9). The most frequent weight of the participants 
in the case group was 51 to 60 kilograms and 50 to 54 kilograms in the control group 
(Figures 4.10 and 4.11). 
4.2.3 Section B: Heart rate as derived from the Monica AN24™ 
recordings (MHR) 
In this section the information relating to the study sample in terms of data that was 
derived from the Monica AN24™ recordings of the maternal Monica AN24™ heart 
rate; basal fetal Monica AN24™ heart rate; success rate of the Monica AN24™ 
recording; duration of Monica AN24™ recording; date of the Monica AN24™ 
recording; time last smoked before Monica AN24™ recording; and time of the Monica 
AN24™ recording was obtained. Data of all the various items was collected unless 
stated otherwise in the discussion of each. 
4.2.3.1 Maternal heart rate as derived from the Monica AN24™ recordings 
(MHR)  
Data of the maternal Monica AN24™ heart rate included the case group (n=102) and 
the control group (n=102). In each group (case and control) the categories were 
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divided into continuous heart rate above 100 beats per minute (bpm) all the time; 
continuous heart rate; tachycardia at the beginning and normal heart rate at the end; 
tachycardia at the end and normal heart rate at the beginning; fluctuations of the 
maternal heart rate to above 100 bpm; and fluctuations. However, there were 
categories where one of the following was not found: fluctuations and tachycardia at 
the beginning; normal heart rate at the end and tachycardia at the end; normal heart 
rate at the beginning and other, in either the case or control group.  These are not 
reflected in the frequency tables. In the case group (Table 4.7), the most frequent 
categories were participants with heart rates fluctuating to above 100 bpm (n=62 or 
60.8%) or remaining above 100 bpm for the total duration of the recording (25.4%). In 
the control group (Table 4.8), the most frequent category was participants that had 
continuous stable heart rates (n= 62 or 60.8%).  
Table 4.7: Maternal heart rate as recorded by Monica AN24™ in case group 
Category Frequency 
(f) 
Percentage 
(%) 
C100 26 25.4 
C 1 1.0 
TB 12 11.8 
TE 1 1.0 
F100 62 60.8 
Total n=102 100 
*C100 - Continuous heart rate at >100 bpm all the time  
*C - Continuous stable heart rate all the time 
*TB - Tachycardia at the beginning, normal heart rate at end 
*TE - Tachycardia at the end normal heart rate at beginning 
*F100 - Fluctuating heart rate at > 100 bpm all the time 
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Table 4.8: Maternal heart rate as recorded by Monica AN24™ in control group  
Category Frequency 
(f) 
Percentage 
(%) 
C100 1 1.0 
C 62 60.8 
F100 18 17.6 
F 21 20.6 
Total n=102 100 
*C100 - Continuous heart rate at >100 bpm all the time  
*C - Continuous stable heart rate all the time 
*F100 - Fluctuating heart rate at > 100 bpm all the time          
*F - Fluctuating heart rate for longer than 10 minutes at a time 
4.2.3.2 Basal fetal heart rate as derived from the Monica AN24™ 
recordings (MHR basal fetal) 
Data of the basal fetal heart rate, as derived from the Monica AN24™ recordings, 
included the case group (n=102) and the control group (n=102). In each group (case 
and control) the categories were divided into continuous stable heart rate; fluctuations 
to above 160 bpm; fluctuations; continuous heart rate above 160 bpm all the time; and 
other. However, categories of which there were no frequency in either case or control 
group, did not appear in the frequency tables. In the case group (Table 4.9), the most 
frequent category were participants with basal fetal heart rates fluctuating to above 
160 bpm (n=38 or 37.3%). In the control group (Table 4.10), the most frequent 
category were participants that had continuous basal fetal heart rates (n=43 or 
42.2%). 
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Table 4.9: Basal fetal heart rate as recorded by Monica AN24™ in case group  
Category Frequency 
(f) 
Percentage 
(%) 
C 31 30.3 
F160 38 37.3 
F 30 29.4 
O 2 2.0 
C160 1 1.0 
Total n=102 100 
*C - Continuous stable heart rate all the time 
*F160 - Fluctuating heart rate at > 160 bpm all the time 
*F - Fluctuating heart rate for longer than 10 minutes at a time 
*O - Other 
*C160 - Continuous heart rate at >160bpm all the time 
 
Table 4.10: Basal fetal heart rate as recorded by Monica AN24™ in control group  
Category Frequency 
(f) 
Percentage 
(%) 
C 43 42.2 
F160 19 18.6 
F 37 36.3 
O 3 2.9 
Total n=102 100 
*C - Continuous stable heart rate all the time 
*F160 - Fluctuating heart rate at > 160 bpm all the time 
*F - Fluctuating heart rate for longer than 10 minutes at a time 
*O - Other 
4.2.3.3 Success rate of Monica AN24™ recording (MHR success rate) 
The mean success rate of the Monica AN24™ heart rate recordings was 99.9 % for 
each of the groups (Table 4.1 and 4.2). The minimum and maximum values for the 
case group were 97.1% and 100.0% respectively (Table 4.1) with a standard deviation 
of 0.4. The minimum and maximum values for the control group were 97.9 and 
100.0% respectively with a standard deviation of 0.3. According to the analyses of 
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variance (Table 4.3) and the Mann-Whitney U Test (Table 4.4) the success rate 
showed no significant difference (p < 0.05) between the two groups. 
4.2.3.4 Duration of Monica AN24™ recording (MHR duration recording) 
Data of the duration of the Monica AN24™ recording included the case group (n=102) 
and the control group (n=102) (Table 4.1 and 4.2) and both groups (Figure 4.12). The 
minimum and maximum values for the case group were 30.0 and 100.0 minutes 
respectively (Table 4.1) with a mean of 53.7 minutes. The minimum and maximum 
values for the control group were 20.0 and 93.0 minutes respectively (Table 4.2) with 
a mean of 55.2 minutes. There was a typical standard distribution in both groups 
(Figure 4.12). The analyses of variance (Table 4.3) revealed that the duration of the 
Monica AN24™ recording did not differ between the two groups. However as the 
duration of the recording was normally distributed, the Mann-Whitney U Test (Table 
4.4) is not applicable and according to analysis of variance (Table 4.3) it showed no 
significance. 
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Figure 4.12: Duration of Monica AN24™ recording  
4.2.3.5 Date of Monica AN24™ recording (MHR date of recording) 
The date of the Monica AN24™ recording includes both groups (n=204), namely the 
case group (n=102) as well as the control group (n=102). The first selected recording 
was done on 20 July 2009 and the last selected recording was done on 4 July 2011. 
4.2.3.6 Time last smoked before Monica AN24™ recording 
The times the last cigarette had been smoked was used to calculate the duration 
between the last cigarette smoked and the actual recording as recorded by the 
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Monica AN24™ device. There were 29 smokers in the case group (Figure 14.13) and 
37 smokers in the control group (Figure 14.14). The time last smoked before the 
Monica AN24™ recording was done was only entered into the data collection 
instrument if the participant had smoked before the recording on the day of recording. 
The majority of smokers were in the control group (Figures 14.3 and 14.14). Amongst 
the case group, the majority (n=7 or 24.0%) of participants had their last cigarette 
before the Monica AN24™ recording between 06h43 and 07h12 (Figure 14.13). 
Amongst the control group, the majority (n=11 or 30.0%) of the participants had their 
last cigarette before the Monica AN24™ recording between 06h00 and 7h12 (Figure 
14.14).  
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Figure 4.13: Time last smoked before Monica AN24™ recording of case group 
GROUP=Control
Histogram of 13. Time last smoked
8%
30%
18%
15% 15%
10%
5%
3:36 AM
4:48 AM
6:00 AM
7:12 AM
8:24 AM
9:36 AM
10:48 AM
12:00 PM
1:12 PM
2:24 PM
13. Time last smoked
0
2
4
6
8
10
12
14
F
re
qu
en
cy
 
Figure 4.14: Time last smoked before Monica AN24™ recording in control group 
4.2.3.7 Time Monica AN24™ recording was done   
As mentioned in section 4.2.3.6, the time the last cigarette had been smoked and the 
time of the recording as recorded by the Monica AN24™ device, were used by the 
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statistician to calculate the time between the last cigarette smoked and the beginning 
of the recording.  The mean elapsed time between the participants’ last cigarette and 
the commencement of the Monica AN24™ recording was one hour and 39 minutes for 
the case group and two hours and five minutes for the control group (Table 4.11). 
Therefore, the case group had a shorter time elapse between the last cigarette 
smoked and the time the recording started. The results are not normally distributed 
(Figure 4.15), thus a bootstrap test was done that confirmed that the time difference 
between the two groups were significantly different (Figure 4.16).  
Table 4.11: Time difference between time last cigarette and recording started of 
both groups individually 
Effect Level 
of 
factor 
N Time 
difference 
mean 
Time 
difference 
Standard 
deviation 
Time 
difference 
Standard 
error 
Time 
difference 
-95.00% 
Time 
difference 
+95.00% 
Total  66 1:54 0:56 0:07 1:40 2:08 
Group Case 29 1:39 0:43 0:08 1:22 1:55 
Group Control 37 2:05 1:03 0:10 1:44 2:27 
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Figure 4.15: Normal probability plot of raw results, demonstrating that the 
distribution was not normal  
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Figure 4.16: Normal probability plot of raw residuals 
It is clear from the findings discussed in the above section that the data from the 
Monica AN24™ recordings revealed that the majority of maternal heart rates in the 
case group were fluctuating to above 100 bpm (n=62 or 60.8%) and in the control 
group were participants that had continuous stable heart rates (n=62 or 60.8%). The 
most frequent category of basal fetal Monica AN24™ heart rate for the case group 
were participants with basal fetal heart rates fluctuating to above 160 bpm (n=38 or 
37.3%)(Table 4.9) and for the control group were participants that had continuous 
stable heart rates (n=43 or 42.2%)(Table 4.10). From these results it is clear that the 
majority of control group Monica AN24™ heart rate recordings were continuous stable 
heart rates with no fluctuations for both the mother and fetus.  There was an overall 
excellent success rate of the quality of the Monica AN24™ recordings for both groups 
with a minimum recording duration of 20.0 to 100.0 minutes. The participants of both 
groups had their last cigarettes before the Monica AN24™ recording by 07:12. 
4.2.4 Section C: Maternal heart rate recorded antenatally (MHRRA) 
In this section the information relating to the study sample in terms of data of the 
number of antenatal visits; the frequency of maternal heart rate recordings; the 
maternal heart rate recorded during - the booking visit; - other antenatal visits; - walk-
in visits; - referrals; - labour; and post-delivery was obtained. As mentioned previously 
in section 4.2.3, the data of all the various items was collected unless stated otherwise 
in the discussion of each.  
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4.2.4.1 Number of antenatal visits  
The total number of participants in both groups where antenatal visits were recorded 
is 192 (Figure 4.17), namely 93 the case group (Table 4.1) and 99 in the control group 
(Table 4.2).  The data of twelve of the participants were not available, nine in the case 
group and three in the control group, as the information was incomplete in the copied 
records. The minimum and maximum number of antenatal visits for the case group 
were 2.0 and 13.0 respectively (table 4.1) with a mean of 5.9 visits. The minimum and 
maximum values for the control group were 1.0 and 13.0 antenatal visits respectively 
(Table 4.2) with a mean of 5.4 visits. The distribution for both groups was slightly 
skewed left (Figure 4.17). The analyses of variance (Table 4.3) as well as the Mann-
Whitney U Test (Table 4.4) did not show a significant difference (p < 0.05) between 
the two groups.  
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Figure 4.17: Number of antenatal visits 
4.2.4.2 Frequency of maternal heart rate recordings 
Data of the frequency of maternal heart rate recordings included the case group 
(n=93) and the control group (n=99) (Table 4.1 and 4.2). As mentioned under section 
4.2.4.1, the data of twelve of the participants were not available, nine from the case 
group and three from the control group, as it was incomplete in the copied records. 
The minimum and maximum frequency of maternal heart rates recorded for the case 
group was 1.0 and 69.0 respectively with a mean of 11.7 (Table 4.1). The minimum 
and maximum frequency of maternal heart rates recorded for the control group was 
1.0 and 65.0 respectively with a mean of 9.5 (Table 4.2). According to the analyses of 
variance (Table 4.3) there was no significant difference (p < 0.05) of the frequency of 
maternal heart rate recordings between the two groups. 
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4.2.4.3 Maternal heart rate recorded during booking visit (MHRRA booking) 
Data of the maternal heart rate recorded during the booking visit included the case 
group (n=101) and the control group (n=102) (Table 4.1 and 4.2). Only one of the 
participant’s data from the case group was unavailable due to incomplete records. 
None of the participants’ heart rates for the case group (Table 4.1) was recorded at 
the booking visit. For the control group (Table 4.2) there was only one instance where 
a participant’s heart rate was recorded at the booking visit. This finding was 
significant, but unfortunately these numbers were too small for statistical analyses. 
4.2.4.4 Maternal heart rate recorded during other antenatal visits (MHRRA 
other ANC visits) 
Data of the maternal heart rate recorded during other antenatal visits included the 
case group (n=101) (Table 4.12) as well as the control group (n=102) (Table 4.13). In 
the case group the majority of participants’ (n=96 or 95.0%) heart rate were never 
recorded (Table 4.12). There were five participants in the case group where the heart 
rates were recorded, more than once. In the majority of participants (n=101 or 99.0%) 
in the control group the heart rate has never been recorded (Table 4.13). There was 
only one participant where the heart rate was recorded 12 times during other 
antenatal visits (Table 4.13). The analyses of variance (Table 4.3) and the Mann-
Whitney U Test (Table 4.4) did not show a significant difference (p < 0.05) of the 
maternal heart rate recorded during other antenatal visits between the two groups.   
Table 4.12: MHRRA other ANC visits of case group 
Amount of visits Frequency 
(f) 
Percentage 
(%) 
0 96 95.0 
1 2 2.0 
3 1 1.0 
4 2 2.0 
Total n=101 100 
 
Table 4.13: MHRRA other ANC visits of control group 
Amount of visits Frequency 
(f) 
Percentage 
(%) 
0 101 99.0 
12 1 1.0 
Total n=102 100 
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4.2.4.5 Maternal heart rate recorded during walk-in visits (MHRRA walk-in 
visits) 
Data of the frequency of maternal heart rate recorded during walk-in visits included 
the case group (n=94) and the control group (n=100) (Table 4.14 and 4.15). The data 
of ten of the participants were unavailable, eight from the case group and two from the 
control group, as it was incomplete in the copied records. In the case group the 
majority of participants’ (n=66 or 70.2%) heart rates were never recorded during walk-
in visits (Table 4.14). However, there were 28 participants (n=28 or 29.8%) from the 
case group where their heart rates were recorded during walk-in visits, the table below 
highlights the instances of these visits. In the control group the majority of participants’ 
(n=75 or 75.0%) heart rates were never recorded during walk-in visits (Table 4.15).  
However, there were 25 participants (n=25 or 25.0%) from the control group where 
their heart rates were recorded during walk-in visits more than once (Table 4.15). The 
analyses of variance (Table 4.3) and the Mann-Whitney U Test (Table 4.4) both did 
not show a significant difference (p < 0.05) of maternal heart rate recorded during 
walk-in visits. 
Table 4.14: MHRRA walk-in visits of case group 
Amount of visits Frequency 
(f) 
Percentage 
(%) 
0 66 70.2 
1 20 21.3 
2 4 4.2 
3 2 2.1 
10 1 1.1 
17 1 1.1 
Total n=94 100 
 
Table 4.15: MHRRA walk-in visits of control group 
Amount of visits Frequency 
(f) 
Percentage 
(%) 
0 75 75.0 
1 21 21.0 
2 3 3.0 
4 1 1.0 
Total n=100 100 
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4.2.4.6 Maternal heart rate recorded during referrals (MHRRA referrals)  
Data of the maternal heart rate recorded during referrals included the case group 
(n=93) and the control group (n=99) (Table 4.1 and 4.2). The data of twelve of the 
participants were not available, nine from the case group and three (n=3) from the 
control group due to incomplete copied records. In the case group most of the 
participants’ (n=52 or 56.0%) heart rates were never recorded during referrals. The 
most instances (maximum value) where their heart rates were recorded during any 
referrals were 15.0, which only occurred with one participant. In the control group 
most of the participants’ (n=67 or 67.7%) heart rates were never recorded during 
referrals. The most instances (maximum value) where their heart rates were recorded 
during any referrals were 22.0, which only occurred with one participant. The analyses 
of variance (Table 4.3) showed no significant difference (p < 0.05) of heart rate 
recorded during referrals between the two groups. 
4.2.4.7 Maternal heart rate recorded during labour (MHRRA labour) 
The discussion of the maternal heart rate recorded during labour included the case 
group (n=93) and the control group (n=99) (Tables 4.1, 4.2 and Figures 4.18 and 
4.19). Data that was lost is the same as explained in section 4.2.4.6. The minimum 
and maximum values of heart rates recorded during labour for the case group was 0.0 
and 22.0 respectively (Table 4.1). The mean heart rate recorded during labour for the 
case group was 4.6 times with a median of 3.0 times which exceeded the mean of 3.6 
times and median of 2.0 times of the control group (Table 4.1 and 4.2). The minimum 
and maximum values of heart rates recorded during labour for the control group was 
0.0 and 23.0 respectively (Table 4.2). Thirty-one (n=31 or 33.0%) of the participants 
from the case group’s heart rates were only recorded once or twice during labour. 
Forty-seven (n=47 or 47.0%) of the participants from the control group’s heart rates 
were only recorded once or twice during labour. The analyses of variance (Table 4.3) 
did not show a significant difference (p < 0.05) of heart rates recorded during labour 
between the two groups. However, the Mann-Whitney U Test (Table 4.5) showed a 
significant difference (p = 0.00) of heart rates recorded during labour between the two 
groups.  
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Figure 4.18: Maternal heart rate recordings during labour of case group 
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Figure 4.19: Maternal heart rate recordings during labour of control group 
4.2.4.8 Maternal heart rate recorded post-delivery (MHRRA post-delivery) 
The data of the maternal heart rate recorded post-delivery included the case group 
(n=93) and the control group (n=99) (Tables 4.1 and 4.2 and Figures 4.20 and 4.21). 
The same amount of lost data as explained in section 4.2.4.6 applies for this section. 
Seventy-one (n=71 or 76.0%) of the participants from the case group’s heart rates 
were recorded in the range of one to five times post-delivery. Seventy-two (n=72 or 
72.0%) of the participants from the control group’s heart rates were recorded in the 
range of one to five times post-delivery. According to the analyses of variance (Table 
4.3) and the Mann-Whitney U Test (table 4.4) there was no significant difference (p < 
0.05) of heart rates recorded during post-delivery between the two groups. 
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Figure 4.20: Maternal heart rate recordings post-delivery of case group 
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Figure 4.21: Maternal heart rate recordings post-delivery of control group 
It is clear from the findings discussed in the above section that the participants from 
the case group had an average of 5.9 antenatal visits and the control group had an 
average number of 5.4 antenatal visits throughout the pregnancy. During the entire 
pregnancy the maternal heart rate was recorded 11.7 times for the case group and 9.5 
times for the control group. 
4.2.5 Section D: Haemoglobin value 
In this section the information relating to the study sample in terms of the data of the 
haemoglobin (Hb) values recorded at the booking visit; 28 to 38 weeks; delivery; and 
the frequency of Hb-values done during the entire antenatal period was obtained. All 
the data of the various items was collected unless stated otherwise, in the discussion 
of each. 
4.2.5.1 Haemoglobin value at booking visit 
The Hb-value at the booking visit included the case group (n=89) and the control 
group (n=93) (Tables 4.1 and 4.2, Figures 4.22 and 4.23). The data of twenty-two 
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(n=22) of the participants were not available due to incomplete copied records, 
thirteen (n=13) from the case group and nine (n=9) from the control group. The 
minimum and maximum Hb-values recorded for the case group was 8.5 and 16.5 g/dL 
respectively with a mean of 12.0 g/dL (Table 4.1). The minimum and maximum Hb-
values recorded for the control group was lower than that of the case group with 8.1 
and 15.3 g/dL respectively and also with a mean of 12.0 g/dL (Table 4.2). There was a 
typical standard distribution in both the case and control groups (Figures 4.22 and 
4.23). According to the analyses of variance (Table 4.3) and the Mann-Whitney U Test 
(Table 4.4) there was no significant difference (p < 0.05) of the frequency of the Hb-
value recorded at the booking visit between the two groups.  
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Figure 4.22: Hb value at booking visit of case group 
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Figure 4.23: Hb value at booking visit of control group 
4.2.5.2 Haemoglobin value at 28 to 38 weeks 
The data of 51 (n=51) of the participants were not available, seventeen (n=17) from 
the case group and 34 (n=34) from the control group, as it was not recorded onto the 
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maternal records. The minimum and maximum Hb-values recorded for the case group 
was 7.0 and 14.0 g/dL respectively with a mean of 10.7 g/dL (Table 4.1). Almost a 
third (n=27 or 32.0%) of participants’ Hb-values were between 9.1 and 10.0 g/dL 
(Figure 4.24). The minimum and maximum Hb-values recorded for the control group 
was 8.0 and 14.0 g/dL respectively with a mean of 10.8 g/dL (Table 4.2). Seventeen 
(n=17 or 25.0%) participants’ Hb-values were between 9.5 and 10.0 g/dL (Figure 
4.25). The lowest Hb-value of 7.0 g/dL of the case group was thus lower than that of 
the control group (Table 4.1). The analyses of variance (Table 4.3) and the Mann-
Whitney U Test (Table 4.4) confirmed that there was no significant difference (p < 
0.05) of the frequency of the Hb-value recorded at 28 to 38 weeks between the two 
groups.  
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Figure 4.24: Hb value at 28 to 38 weeks of case group 
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Figure 4.25: Hb value at 28 to 38 weeks of control group 
4.2.5.3 Haemoglobin value at delivery 
At delivery only 46 (n=46) of the participants from the case group and 31 (n=31) of the 
participants from the control group’s Hb-values were recorded. The minimum and 
maximum Hb-values recorded for the case group was 7.1 and 15.5 g/dL respectively 
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with a mean of 10.5 g/dL (Table 4.2). The minimum and maximum Hb-values 
recorded for the control group was 6.8 g/dL and 14.7 g/dL respectively with a mean of 
11.0 g/dL (Table 4.1). According to the analyses of variance (Table 4.3) and the 
Mann-Whitney U Test (table 4.4) there was no significant difference (p < 0.05) of the 
frequency of the Hb value recorded at delivery between the two groups.  
4.2.5.4 Frequency of haemoglobin values done during entire antenatal 
period 
The data of the frequency of Hb-values included 91 (n=91) of the participants from the 
case group and 95 (n=95) of participants from the control group’s Hb-values that were 
recorded. The remaining 11 (n=11) for the case group and seven (n=7) for the control 
group’s records were incomplete. The frequency of Hb’s done for the case group 
ranged from zero to six times (Figure 4.26). Just over a third (n=34 or 37.0%) of 
participants from the case group’s Hb’s were recorded twice and the distribution was 
typically standard (Figure 4.26). The frequency of Hb’s done for the control group 
ranged from zero to 5 times (Figure 4.27). The majority of participants’ Hb’s were 
done twice or three time with a bimodal distribution of 34 (n=34 or 36.0%) (Figure 
4.27). The median for the number of Hb examinations in both groups was 3, but the 
mean in the case group was 2.9 and in the control group 2.5. The analyses of 
variance (Table 4.3) and the Mann-Whitney U Test (Table 4.4) both revealed a 
significant difference (p < 0.05) of the frequency of Hb values done during the entire 
antenatal period between the two groups.  
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Figure 4.26: Hb frequency of case group 
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Figure 4.27: Hb frequency of control group 
The abovementioned findings of this section will further be discussed in chapter 5. 
4.2.6 Section E: Maternal outcome 
In this section the information relating to the study sample in terms of the data of the 
facility of delivery; mode of delivery; pre-existing conditions; maternal morbidity; and 
maternal mortality was obtained. All the data for the various items were collected 
unless it was stated otherwise in the discussion of each. 
4.2.6.1 Facility of delivery 
The data for the facility of delivery of one of the participants from the case group was 
incomplete. Most of the participants (n=52 or 51.0%) from the case group delivered at 
a Midwife Obstetric Unit (MOU) (Figure 4.28). Also from the case group, 40 
participants (n=40 or 40.0%) of the participants delivered at Karl Bremer Hospital 
(KBH), only nine (or 9.0%) participants delivered at Tygerberg Hospital. No (n=0 or 
0.0%) deliveries of the case group occurred at other facilities. The majority of 
participants from the control group (n=63 or 62.0%) delivered at a MOU (figure 4.29), 
which is 11.0% more than that of the case group. Twenty-six (25.0%) participants of 
the control group delivered at KBH, ten (n=10 or 10%) at Tygerberg Hospital and only 
three participants (n= 3 or 3.0%) delivered at other facilities.  
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Figure 4.28: Facility of delivery of case group 
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Figure 4.29: Facility of delivery of control group 
4.2.6.2 Mode of delivery 
The outcome of the mode of delivery was similar for the case and the control groups. 
The majority of participants for both the case (n=85 or 83.3%) (Table 4.16) and control 
group (n=86 or 84.3%) (Table 4.17) had normal vertex deliveries. Fifteen (n= 15 or 
14.7%) participants from both the case and control groups had caesarean sections 
(Tables 4.16 and 4.17). One (n=1 or 1.0%) participant from each, the case and control 
groups had a vaginal breech delivery (Tables 4.16 and 4.17). Only one (n=1 or 1.0%) 
(Table 4.16) participant from the case group had a forceps delivery. There were no 
(n=0 or 0.0%) vacuum extractions in any of the groups. 
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Table 4.16: Mode of delivery of case group 
Mode of delivery Frequency 
(f) 
Percentage 
(%) 
Normal vertex delivery 85 83.3 
Vaginal breech delivery 1 1.0 
Caesarean section 15 14.7 
Forceps delivery 1 1.0 
Total n=102 100 
 
Table 4.17: Mode of delivery of control group 
Mode of delivery Frequency 
(f) 
Percentage 
(%) 
Normal vertex delivery 86 84.3 
Vaginal breech delivery 1 1.0 
Caesarean section 15 14.7 
Total n=102 100 
 
4.2.6.3 Pre-existing conditions 
One participant from the case group and one participant from the control group’s data 
was incomplete from the copied records. The categories for this outcome were divided 
into coronary artery disease; myocardial infarction; cardiomyopathy; valvular and 
congenital heart disease; other; and healthy. The majority (n=90 or 90.0%) of 
participants from the case group were healthy and only 11 (n=11 or 11.0%) of this 
group were categorised as “other”. The group in the “other” category had diseases 
such as chronic hypertension, asthma, renal disease, drug addiction and HIV. Most 
(n=86 or 86.0%) of the participants from the control group were healthy and only 15 
(n=15 or 15.0%) of this group were categorised as “other”. None of the participants 
from both the case and control group had coronary artery disease; myocardial 
infarction; cardiomyopathy; valvular heart disease; or congenital heart disease. Thus, 
there were no pre-existing cardiac conditions diagnosed during the course of this 
study. 
4.2.6.4 Maternal morbidity 
The data of nine participants from the case group and four participants from the 
control group were unavailable due to incomplete records. The categories for this 
outcome were divided into anaemia; cardiac disease; cardiac complications; infection; 
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and haematological conditions; other; and healthy. The results of maternal morbidity 
were similar for the case and the control group. More than half (n=50 or 54.0%) of the 
participants from the case group (Figure 4.30) were healthy which was less than the 
control group (Figure 4.31) that was just over two thirds (n=66 or 67.0%). Of the case 
group 15% (n=14) had “other” health complications; 18% (n=17) had infection; 10% 
(n=9) were diagnosed with anaemia; and three percent (n=3) had haematological 
conditions such as severe haemorrhage. Of the control group 12.0% (n=12) had 
“other” health complications; nine percent (n=9) had infection; eight percent (n=8) 
were diagnosed with anaemia; and three percent (n=3) had haematological conditions 
such as severe haemorrhage. 
A summary of a number of participants diagnosed with infection after the Monica 
AN24™ recording was done and is displayed in Table 4.18. The most common 
possible origin of infection was the operation as indicated by post-operative 
temperature spikes. The other possible origin of infections such as pyeloniphritis and 
chorioamnionitis were also prevalent. This table displays the most common possible 
origins of infection that was diagnosed after the Monica AN24™ recording was done. 
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Figure 4.30: Maternal morbidity of case group 
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Figure 4.31: Maternal morbidity of control group 
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Table 4.18: Summary of participant’s with infection diagnosed after Monica AN24™ recording 
No Pat ID Case/ 
Control 
Date when 
Monica 
AN24™ 
recording 
was done 
Date infection 
was diagnosed 
Time from Monica 
AN24™ recording 
to diagnosis of 
infection 
Possible origin of 
infection 
Indication for 
cesarean section 
Date of 
Delivery 
Time passed 
from infection 
diagnosed to 
*DOB 
29 01896 Case 23/02/2010 09/03/2010 2 weeks Pyelonephritis Not applicable 13/03/2010 4 days 
55 02058 Case 06/05/2010 16/06/2010 6 weeks Leucocytes in urine Poor progress 17/06/2010 1 day 
62 02007 Case 14/04/2010 13/06/2010 4 weeks, 1 day Post-operative 
temperature spike; no 
diagnosis 
Cephalopelvic 
disproportion 
13/06/2010 Same day 
63 01980 Control 14/05/2010 28/06/2010 6 weeks, 3 days Post-operative 
temperature spike; no 
diagnosis 
Poor progress 27/06/2010 1 day after DOB 
65 02152 Case 20/05/2010 15/06/2010 3 weeks, 5 days Chorioamnionitis Not applicable 15/06/2010 9 hours 
84 02186 Control 02/08/2010 21/09/2010 7 weeks, 1 day Post-operative 
temperature spike; no 
diagnosis 
Fetal distress Poor 
progress 
20/09/2010 1 day after DOB 
133 02695 Case 04/01/2011 06/02/2011 4 weeks, 5 days Post-operative 
temperature spike; no 
diagnosis 
Fetal distress 05/02/2011 1 Day after DOB 
135 02617 Case 05/01/2011 09/02/2011 5 weeks Post-operative 
temperature spike no 
diagnoses 
Fetal distress 08/02/2011 1 Day after DOB 
167 02890 Case 30/03/2011 04/05/2011 5 weeks Unknown Not applicable 04/05/2011 Same day 
*DOB - Date of birth
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4.2.6.5 Maternal mortality 
Data collected for maternal mortality for both the case and the control group was 
categorised as either a “yes” or “no”. The results of the case group equalled those of the 
control group. Only two participants died, one in the case (1.0%) and one in the control 
(1.0%) group. At the time of data collection, both 101 (99.0%) participants in the case and 
101 (99.0%) participants in the control group were alive.  
It is clear from the findings discussed in the above section that the majority of participants 
had normal vertex deliveries and delivered at a MOU. There were little pre-existing 
conditions listed as “other” in participants from the case (n=11 or 11.0%) and control group 
(n=15 or 15.0%). There were various maternal complications (refer to section 4.2.6.4) and 
only 1.0% maternal mortalities for each group. 
4.2.7 Section F: Neonatal outcome 
The information relating to the study sample in terms of data recorded of the neonatal 
gender; neonatal morbidity; neonatal mortality; birth weight; gestational age at delivery; 
and small for gestational age was obtained in this section. Unless stated otherwise at each 
item, all the data of the various items were collected. 
4.2.7.1 Neonatal gender 
The discussion of neonatal gender included each group, namely the case group (n=102) 
and control group (n=102) individually. Fifty-five percent (n=56) were female babies and 
45% (n=46 or 45.0%) were male babies from the case group. Of the control group 49.0% 
(n=50) were female babies and 51.0%   (n=52) were male babies. 
4.2.7.2 Neonatal morbidity 
The data of eight participants from the case group and two (n=2) participants from the 
control group were unavailable due to incomplete records. The categories for neonatal 
morbidity were divided into respiratory distress syndrome; infection; neonatal jaundice; 
other; and healthy.  The majority (n=87 or 92.6%) of babies from the case group were 
healthy at the time data was collected, 1.1% (n=1) of babies were categorised as “other” 
(congenital cardiac lesion), 4.2% (n=4) of babies had respiratory distress syndrome and 
2.1% (n=2) of babies had neonatal jaundice (Table 4.19). No baby in the case group was 
diagnosed with infection at the time data was collected. Most babies (n=90 or 90.0%) from 
the control group were healthy at the time data was collected, 4.0% (n=4) of babies were 
categorised as “other” (IUGR, congenital cardiac lesion and thrombocytopaenia), 1.0% 
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(n=1) of babies had respiratory distress syndrome, 4.0% (n=4) were diagnosed with 
neonatal jaundice and 1.0 (or 1.0%) of babies had infection (Table 4.20).  
Table 4.19: Neonatal morbidity in case group 
Category Frequency 
(f) 
Percentage 
(%) 
Healthy 87 92.6 
Other 1 1.1 
Respiratory distress syndrome 4 4.2 
Neonatal jaundice 2 2.1 
Total n=94 100 
 
Table 4.20: Neonatal morbidity in control group 
Category Frequency 
(f) 
Percentage 
(%) 
Healthy 90 90.0 
Other 4 4.0 
Respiratory distress syndrome 1 1.0 
Neonatal jaundice 4 4.0 
Infection 1 1.0 
Total n=100 100 
 
4.2.7.3 Neonatal mortality 
Data collected for neonatal mortality for both the case and the control group was 
categorised as either a “yes” or “no”. The data of one of the participants were incomplete; 
therefore it could not be collected. The categories for neonatal mortality were divided into 
alive; miscarriage; intra-uterine death; neonatal death; and infant death.  Almost all the 
babies (n=101 or 99.0%) in the case group’s participants were alive at the time the data 
was collected. Only one baby from a participant (or 1.0%) in the case group had a 
neonatal death due to a congenital cardiac lesion. The control group had 99 (n=99 or 
98%) babies that were alive at the time data collection was completed; there were one 
(1.0%) infant death due to a congenital cardiac lesion and one (1.0%) neonatal death due 
to IUGR.  
4.2.7.4 Birth weight 
Although each individual birth weight was typed into the spreadsheet, the birth weight was 
expressed in groups of 500g on the histograms of each group (Figures 4.32 and 4.33). In 
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the case group the birth weight ranged from 2000g to 5000g. Almost half of the neonates 
(n=48 or 47.0%) in the case group weighed between 3000g and 3499g (Figure 4.32) and 
nearly a third of the neonates (n=30 or 29.0%) weighed between 2500g and 2999g. In the 
control group the birth weight ranged from 1000g to 4500g (Figure 4.33). There was a 
typical standard distribution of birth weights in the control group (Figure 4.33). About a 
third of the neonates (n= 34 or 33.0%) from the control group weighed between 3000g and 
3499g and almost a third of the neonates (n=30 or 29.0%) weighed between 2500g and 
2999g (Figure 4.33). According to the analyses of variance (Table 4.3) there was a 
significant difference (p < 0.05) of the birth weight between the two groups, as the mean 
birth weight in the case group was 3226g and 3032g in the control group (Table 4.21). 
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Figure 4.32: Birth weight of case group 
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Figure 4.33: Birth weight of control group 
4.2.7.5 Gestational age at delivery 
Although the information on gestational age at delivery was collected in weeks and days 
separately the data of only the completed weeks are displayed and discussed in this 
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section (Figures 4.34 and 4.35). The gestational age in weeks for the case group ranged 
from 36 weeks (n=2 or 2.0%) to 42 weeks (n=5 or 5.0%) with a mean and median of 39.2 
and 39 weeks respectively (Figure 4.34 and Table 4.1). The majority of participant’s from 
the case group delivered at 39 weeks (n=28 or 27.0%). The gestational age in weeks for 
the control group ranged from 34 weeks (n=1 or 1%) to 42 weeks (n=6 or 6%) with a mean 
and median of 38.9 and 39 weeks respectively (Figure 4.35 and Table 4.2). The majority 
of participants from the control group delivered at 40 weeks (n=23 or 23.0%). According to 
the analyses of variance (Table 4.3) the groups did not differ significantly. As summarised 
in Table 4.21, there was little difference in the gestational age, but a greater significance in 
birth weight according to the Mann-Whitney U Test. 
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Figure 4.34: Gestational age at delivery in weeks of case group 
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Figure 4.35: Gestational age at delivery in weeks of control group 
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Table 4.21: Compared findings of gestational age, birth weight and p-value of Mann-
Whitney U Test 
 Case Control Mann-Whitney U Test 
p-value 
GA weeks (mean) 39.2 38.9 0.27 
Birth weight (mean) 3226 g 3032 g 0.02 
 
4.2.7.6 Small for gestational age (SGA) 
Based on the birth weight and the gestational age at delivery, it could be determined 
whether the neonates were small for gestational age. The data collected for this variable 
was based on the single centile chart designed for the population of the Western Cape 
(Theron & Thompson, 1995:1291). Only 5.9% (n=6) of neonates from the case group were 
small for their gestational age and 94.1% (n=96) were not small for their gestational age 
(Table 4.22). Almost a fifth (n=20 or 19.6%) of neonates from the control group were small 
for their gestational age and 80.4% (n=82) were not small for their gestational age (Table 
4.23).  
Table 4.22: Small for gestational age of case group 
Small for gestational age Frequency 
(f) 
Percentage 
(%) 
No 96 94.1 
Yes 6 5.9 
Total n=102 100 
 
Table 4.23: Small for gestational age of control group 
Small for gestational age Frequency 
(f) 
Percentage 
(%) 
No 82 80.4 
Yes 20 19.6 
Total n=102 100 
It is clear from the findings discussed in the above section that the majority of neonates in 
both groups were healthy. There was an overall mortality of 3.0% in both groups. There 
was a difference in mean birth weight of 194g between the two groups. Further discussion 
regarding the birth weight continues in chapter 5. 
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4.2.8 Section G: Apgar scores 
The information relating to the study in terms of Apgar scores one minute, five minutes 
and ten minutes was obtained in this section. All the data of the various items in this 
section were collected unless stated otherwise.  
4.2.8.1 Apgar score at one minute 
Data of the Apgar scores at one minute included the case group (n=102) and the control 
group (n=97). Five of the participants from the control group’s data were unavailable due 
to incomplete records. The options of values for the Apgar scores were on a scale from 
one to ten. Value one was the lowest and value ten was the highest score. The results of 
the Apgar scores for the case group ranged from five to ten. The majority (n=86 or 84.3%) 
from the case group scored nine out of ten at one minute (Table 4.24). The results of the 
Apgar scores for the control group ranged from two to nine. Most (n=84 or 87%) 
participants from the control group also scored nine out of ten (Table 4.25). The mean 
Apgar score was 8.8 for the case group and 8.7 for the control group. The analyses of 
variance (Table 4.3) and the Mann-Whitney U Test (table 4.4) all showed that there was 
no significant difference (p < 0.05) of the Apgar scores at one minute between the two 
groups.  
Table 4.24: Apgar score at one minute of case group 
Apgar score Frequency 
(f) 
Percentage 
(%) 
5 2 2.0 
6 2 2.0 
7 1 1.0 
8 8 7.8 
9 86 84.3 
10 3 2.9 
Total n=102 100 
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Table 4.25: Apgar score at one minute of control group 
Apgar score Frequency 
(f) 
Percentage 
(%) 
2 1 1.0 
5 2 2.0 
6 1 1.0 
8 9 9.0 
9 84 87.0 
Total n=97 100 
 
4.2.8.2 Apgar score at five minutes 
The data of the Apgar scores at five minute included the case group (n=102) and the 
control group (n=97). Five of the participants from the control group’s data were also 
unavailable due to incomplete records. The arrangement of scoring is the same as 
explained in section 4.2.8.1. The results of the Apgar scores at five minutes for the case 
group ranged from six to ten. Most (n=87 or 85.3%) participants in the case group scored 
ten out of ten for their five minute Apgar score (Table 4.26). The results of the Apgar 
scores at five minutes for the control group ranged from two to ten. The majority (n=87 or 
90.0%) of participants in the control group also scored ten out of ten at their five minute 
Apgar score (Table 4.27).  The mean Apgar score was 9.8 for both groups. The analyses 
of variance (Table 4.3) revealed no significant difference (p < 0.05) of the Apgar scores at 
five minutes between the two groups. However, the Mann-Whitney U Test (table 4.4) 
showed that there was a significant difference (p < 0.05) of the Apgar scores at five 
minutes between the two groups.  
Table 4.26: Apgar score at five minutes of case group 
Apgar score Frequency 
(f) 
Percentage 
(%) 
6 1 1.0 
8 3 2.9 
9 11 10.8 
10 87 85.3 
Total n=102 100 
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Table 4.27: APGAR score at five minutes of control group 
Apgar score Frequency 
(f) 
Percentage 
(%) 
2 1 1.0 
8 1 1.0 
9 8 8.0 
10 87 90.0 
Total n=97 100 
 
4.2.8.3 Apgar score at ten minutes 
Data of the Apgar scores at ten minutes included the case group (n=51) and the control 
group (n=49). The data of 50 participants from case group and 53 participants from the 
control group were unavailable due to incomplete records. The arrangement of scoring is 
the same as explained in section 4.2.8.1. The results of the Apgar scores at ten minutes 
for the case group ranged from eight to ten. The results of the majority (n=48 or 94.1%) of 
data for the case group scored ten out of ten for the ten minute Apgar score. The results of 
the Apgar scores at ten minutes for the control group ranged from one to ten. The results 
of most (n=47 or 96.0%) of data for the control group also scored ten out of ten for the ten 
minute Apgar score. The mean Apgar score was 9.9 for the case group and 9.8 for the 
control group. The analyses of variance (table 4.3) as well as the Mann-Whitney U Test 
(table 4.4) revealed no significant difference (p < 0.05) of the Apgar scores at ten minutes 
between the two groups.  
It is clear from the findings discussed in the above section that the overall majority of 
Apgar scores were good. The low Apgar scores were in the minority of cases. 
4.2.9 The prevalence of maternal tachycardia in late pregnancy 
The overall prevalence of maternal tachycardia was calculated by dividing the total 
number of participants who presented with maternal tachycardia (n=102 case group) 
through the total number of Monica AN24™ recordings that were analysed (total target 
population N=1431). Therefore the calculated percentage of the prevalence rate of 
maternal tachycardia in late pregnancy for this ancillary study is 7.1% rounded off to the 
first decimal.   
Stellenbosch University  http://scholar.sun.ac.za
95 
 
4.3 CONCLUSION 
The data collected in this study was analysed and discussed in chapter 4. The researcher 
succeeded in successfully exploring and achieving the following objectives designed for 
this study, i.e.:  
The prevalence of maternal tachycardia at 34 to 38 weeks gestation in a sub-population of 
patients enrolled in the Safe Passage Study was determined. The empirical findings with a 
control group of normal maternal heart rates during late pregnancy were compared. The 
presence of anaemia in both groups were determined and compared. Any underlying pre-
existing conditions as well as pre-existing cardiac conditions were explored and the 
perinatal outcomes of the participants were determined. 
Chapter 5 includes a further discussion on the synthesis as well as the hypothesis 
intended for this study. Appropriate recommendations were presented, certain limitations 
were illustrated and the chapter was brought to an end with a final conclusion. 
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CHAPTER 5: DISCUSSION, CONCLUSIONS AND 
RECOMMENDATIONS  
5.1 INTRODUCTION 
In this chapter, an overview of the key findings is given; conclusions are drawn as to 
whether maternal tachycardia in late pregnancy is associated with underlying major 
cardiac disease, maternal anaemia; and adverse maternal and perinatal outcomes.  
Where appropriate, the findings are measured and compared with previous studies in the 
same field.  
Suitable recommendations are given as identified by the researcher and experts in the 
field of study. A number of limitations of this study are highlighted in this chapter and the 
latter is ended off with a final conclusion.  
5.2 DISCUSSION AND CONCLUSIONS  
The findings of maternal tachycardia in this study supports the view held by Reide and 
Yentis (2010:315) referred to in section 2.3 that in women with tachycardia and arrythmias, 
the symptoms are absent or mild in most cases, however the authors claim that all 
pregnant women are prone to tachycardia and arrythmias which does not completely 
agree with this study’s findings of a 7.1 % (n=102) prevalence of maternal tachycardia.  
Referring to section 2.4.5.9, the results of Carson et al.’s (2002:42) study to determine the 
effect of obesity and position on heart rate in pregnancy confirmed that more women are 
tachycardic when in the seated position (39%) than when on their left side (29%; p<0.001). 
The abovementioned study also concluded that the women that presented with 
tachycardia also had a higher BMI. As mentioned in section 4.2.2.7 the findings of 
maternal weight for this study did not reveal any significant difference between the 
participants with maternal tachycardia and those that had normal heart rates. Although 
Carson et al.’s (2002:42) study proved significant findings, in context of the findings of 
maternal weight; no significance could be established in this study.  
5.2.1 Significant findings according to the Mann-Whitney U Test 
As shown in various analyses, the data was often not normally distributed. Under these 
circumstances the non-parametric Mann-Whitney U test was used to determine statistical 
significance. The significant p-values of the Mann-Whitney U test are displayed in table 5.1 
and these findings are discussed in the next section at it gives a summary of the most 
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important findings. This follows with an evaluation and discussion on the hypotheses that 
were formulated for this study.    
Table 5.1: Significant p-value of Mann-Whitney U Test 
Variable Significant p-value 
Maternal age 0.04 
Gravidity 0.01 
Parity 0.00 
Duration of Monica AN24™recording 0.00 
Frequency of maternal heart rate recordings 0.05 
Haemoglobin frequency 0.04 
Birth weight 0.02 
 
5.2.1.1 Maternal age, gravidity and parity 
A comparison between maternal ages revealed that the case group’s participants were 
younger (mean age of 22.9 years) than the control group’s participants (mean age of 24.4 
years). As mentioned in section 4.2.2.1 the p-value for the Mann-Whitney U test was 0.04 
indicating that there was a significant difference between the case and the control group 
(Table 5.1). 
Illustrated in section 4.2.2.3 and tables 4.1 and 4.2 the mean gravidity of the case group of 
1.8 was less than that of the control group of 2.2. The p-value for the Mann-Whitney U test 
was 0.01 (Table 5.1) indicating a statistical significant difference. The mean parity (refer to 
section 4.2.2.4 and tables 4.1 and 4.2) for the case group of 0.7 was lower than that of the 
control group of 1.1. The Mann-Whitney U test revealed that it also differed significantly 
between the two groups (Table 5.1). 
An evaluation of the abovementioned findings, a clear association can be drawn to the 
maternal age, gravidity and parity. The case group’s participants that had maternal 
tachycardia were younger than the control group’s participants. Therefore, the researcher 
conclude that this explains why the average gravidity and parity was also lower in the case 
group, it may be because these participants were younger. No obvious reason for this 
finding of the lower maternal age in the case group could be identified. 
The findings of Carson et al.’s (2002:42) study revealed no significant difference of 
maternal age, gravidity and parity in women with normal heart rates compared to women 
that presented with tachycardia. In the extensive scanning of the literature, no additional 
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reports could be found where maternal age, gravidity and parity were associated with 
prevalence of tachycardia during pregnancy. 
5.2.1.2 Duration of Monica AN24™ recording (MHR duration recording) 
As mentioned in section 4.2.3.4 the average Monica AN24™ recording duration for the 
case group was 53.7 minutes (Table 4.1) that was less than the average Monica AN24™ 
recording duration of 55.2 minutes (Table 4.2) of the control group. With a p-value of 0.00 
the Mann-Whitney U test (Table 5.1) revealed a statistically significant difference between 
the two groups. As the data of the duration of the Monica AN24™ recording was actually 
normally distributed, the analysis of variance (Table 4.3) is considered to be the more 
statistically appropriate test as no significant difference (p < 0.05) was found between the 
two groups. The difference of less than two minutes between the two groups is, according 
to the researcher, of little clinical value. In addition, the selection of participants where the 
duration of the recording had met specific requirements could be the reason why the 
durations of the recordings were almost similar.  
5.2.1.3 Frequency of maternal heart rate recordings 
An evaluation of the findings, referring to section 4.2.4.2 and tables 4.1 and 4.2 reveals 
that the heart rates of participants from the case group were recorded an average of 11.7 
times which was more than the average heart rates recorded of the participants from the 
control group of 9.5 times. This leads to the question, why was maternal heart rate more 
regularly recorded in the case group? The data was not normally distributed, the median of 
the case group is 8.0 and the control group is 6.0. The Mann-Whitney U test revealed a p-
value of 0.05 (Table 5.1), which proves a statistical significant difference between the two 
groups.  
Although one can argue that some participants in the case group could have presented 
with more “adverse incidents”, the number of complicated cases such as pre-existing 
conditions of anaemia were not significantly different in both groups. Therefore, the clinical 
significance of these findings is in question as no possible reason could be found why the 
maternal heart rate was recorded more often in the case group. In the extensive scanning 
of the literature, no report could be found where frequency of pulse rate recordings in 
normal pregnancies was associated with possible poor outcome.  
A Science Direct, Scopus, MD Consult, Cinahl Ebscohost and Pubmed search was done 
on with the key words: “maternal heart rate recordings”; “frequency of maternal heart rate 
recordings”; “maternal heart rate”; “maternal tachycardia” revealed limited results for the 
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time span 2006 to present. No study could be found to compare findings within a 
comparable context.   
5.2.1.4 Haemoglobin value frequency 
The mean frequency of recorded haemoglobin (Hb) values for the case group was 2.9 and 
the control group was 2.5, which means that the Hb-values were recorded an average of 
0.4 times more in the case group than in the control group. The Mann Whitney U test 
showed that there was a statistical significant difference between the two groups with a p-
value of 0.04 (Table 5.1).  
One can argue that the mean number of antenatal visits which is more in the case group 
(5.9 times) (Table 4.1) than the control group (5.4 times) (Table 4.2) could have had an 
effect on the number of times the Hb values were recorded. But the reason for this 
increase remains uncertain. In addition, from a clinical point of view, the small difference of 
0.4 is of little significance.  
As mentioned in section 5.2.1.3, a literature search was done on the following databases: 
Science Direct, Scopus, MD Consult, Cinahl Ebscohost and Pubmed. Keywords such as 
“frequency of Hb recordings” and “antenatal visits” revealed limited results for the time 
span 2006 to present. Therefore no research could be found to compare findings in a 
comparable context of this study.  
5.2.1.5 Birth weight  
The mean and median birth weight for the case group was 3226g and 3220g respectively 
(Table 4.1). The mean and median birth weight for the control group was 3032g and 
3050g respectively (Table 4.2). The Mann-Whitney U test revealed a statistical 
significance in birth weight between the two groups.  
This finding raises questions as to why there was an increased birth weight in infants 
whose mothers had tachycardia? Literature findings revealed that the tachycardia 
increased the maternal cardiac output and therefore could increase uteroplacental blood 
supply with subsequent increase in fetal requirements. The study of Gelson, Curry, 
Gatzoulis, Swan, Lupton, Steer and Johnson (2011:887) is a retrospective cohort study 
done in London to determine the effect of maternal heart disease on fetal growth and 
neonatal outcomes, the authors contend that a woman’s cardiovascular adaptation to 
pregnancy is important because it determines the uteroplacental perfusion. Although 
cardiac disease can be associated with poor nutrition and hypoxia it seems likely that 
cardiovascular performance is the major influence of fetal growth. Also, this study 
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furthermore validated that women with cardiac disease are more likely than those in a 
control population to give birth to newborns with low percentile birth weights at an earlier 
gestational age which results in a higher rate of perinatal complications in these women. 
The authors recognised that the strongest predictors of low birth weight and preterm 
delivery are maternal cyanosis or reduced output or both. 
It was decided to list only the significant findings according to the Mann-Whitney U test 
(Table 5.1), as there were too many negative findings to discuss. The decision to list the 
duration of recording under table 5.1 could be questioned as the findings were normally 
distributed. According to the analysis of variance test (Table 4.3) the difference (p=0.22) 
was not significant. 
5.2.2 Hypotheses 
The following research hypotheses were formulated for this study in section 1.2.1 in 
chapter one and discussed as follows. 
5.2.2.1 Hypothesis 1: Maternal tachycardia in late pregnancy is associated with 
underlying major cardiac disease 
This hypothesis was designed to determine whether there is an association between 
maternal tachycardia and underlying major cardiac disease. Referring to section 4.2.6.3 
none of the participants from the case and control group have been diagnosed with any of 
the pre-existing cardiac conditions. There were also no cardiac complications in either 
group. 
As there were no pre-existing cardiac conditions in any of the groups and no cardiac 
complications during pregnancy and delivery, this hypothesis could not be tested. As the 
prevalence rate of cardiac disease in pregnancy is particularly rare, a very large study 
would be needed to test this hypothesis. 
5.2.2.2 Hypothesis 2: Maternal tachycardia in late pregnancy is associated with 
maternal anaemia  
This hypothesis was formulated to determine whether there is an association between 
maternal tachycardia in late pregnancy and maternal anaemia. The results referred to in 
section 4.2.5.2 and 4.2.6.4 as well as further analyses that are discussed below was 
considered to determine the abovementioned hypothesised association. The parameters 
for anaemia in pregnancy have been defined in section 2.2.3. As referred to the section 
mentioned above, any participant with an Hb-value lower than 11.0 g/dL is considered to 
be anaemic (Woods, 2006:13).  
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Reflecting the results for the Hb-value at 28 to 38 weeks, the minimum Hb-values for the 
case and control groups were 7.0 g/dL and 8.0 g/dL respectively (section 4.2.5.2). The 
mean and median Hb-values for the case group were 10.7 g/dL and 10.5 g/dL respectively 
(Table 4.1). The mean and median Hb-values for the control group were 10.8 g/dL and 
11.0 g/dL respectively. There was an increased frequency of mild anaemia (Hb-values  < 
11.0 g/dL) in the case group (55.0%) compared to that of the control group (47.0%). 
However, the Mann-Whitney U test revealed no statistically significant difference of the 
Hb-values at 28 to 38 weeks between the case and the control groups.  
Reflecting the results of maternal morbidity, the incidence of anaemia in the case group 
(10%) was more than the control group (8%) (section 4.2.6.4). Further statistical tests 
were done to compare the findings of the participants Hb-values between 28 to 38 weeks 
and the participants that had anaemia in the outcome of the study. The box plot below 
presents the difference between the Hb-values of participants at 28 to 38 weeks and the 
outcome of anaemia (Figure 5.1). The median for the participants that were not diagnosed 
with anaemia was 11.0 g/dL and the median Hb-value for the participants that were 
diagnosed with anaemia was 9.0 g/dL.  
A bootstrap test was done which clearly demonstrates a bigger decline in Hb-values in the 
control group than in the case group (Figure 5.2). The Bonferroni test was applied and 
confirmed a significant difference (p=0.02) between the two variables of the control group. 
However, this test confirmed that there was no significant difference (p=0.20) between the 
two variables of the case group. 
The null hypothesis in this instance was accepted as no statistical significant difference 
could be found to prove that maternal tachycardia in late pregnancy was associated with 
maternal anaemia. The Hb-values of the participants were done around the time the most 
participants had their Monica AN24™ recording. Since no statistical significant evidence in 
this study could be found to substantiate this hypothesis, the researcher concludes that 
mild maternal anaemia did not have an effect on the maternal heart rate in late pregnancy. 
Therefore this hypothesis could not be substantiated and was rejected.  
According to the guidelines for maternity care in South Africa (Department of Health, 
2007), anaemia is classified into two categories, mild anaemia (Hb value of 7.0 to 10.9 
g/dL) and severe anaemia (Hb value of less than 7.0 g/dL). As mentioned in the beginning 
of this section, the mean Hb at 28 to 38 weeks gestation was 10.7 g/dL for the case and 
10.8 g/dL for the control groups. The results from this study revealed that there were only 
cases with mild anaemia during late pregnancy (28 to 38 weeks gestation) and no cases 
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with severe anaemia.  This hypothesis was rejected on the basis that the anaemia cases 
were not severe in nature but mild. The management of a patient with iron deficiency 
anaemia in pregnancy suggests that a Hb-value less than 8 g/dL with tachycardia or 
shortness of breath should be admitted to hospital for a blood transfusion (Woods, 
2006:13). This clarifies a severe case of anaemia as it relates to tachycardia during 
pregnancy.  
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Figure 5.1: Box plot of Hb values of both groups at 28 to 38 weeks versus anaemia 
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Figure 5.2: Bootstrap test of Hb values of both groups at 28 to 38 weeks versus 
anaemia  
5.2.2.3 Hypothesis 3: Maternal tachycardia in late pregnancy is associated with 
adverse maternal and perinatal outcomes 
This hypothesis was designed to determine an association between maternal tachycardia 
and specific adverse maternal outcomes as well as specific perinatal outcomes. Maternal 
outcomes were divided into maternal morbidity and maternal mortality. Perinatal outcomes 
were divided into birth weight, Apgar score, neonatal morbidity and neonatal mortality.  
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Table 5.2 displays a summary of the maternal morbidity that occurred in the case and the 
control group. As mentioned in section 4.2.6.4 the total maternal morbidity for the case 
group was higher (46.0% or n=43) when compared to the control group, which had only a 
total morbidity of 33.0% (n=32). Apart from haematological conditions the case group had 
a little more (3.0% or n=3) participants who had “other” complications, two percent more 
participants had anaemia and twice the frequency of infection. Referring to section 4.2.6.4 
and table 4.19, the time difference between the Monica AN24™ recordings to the 
diagnosis of infection varied between two weeks, zero days and seven weeks, one day. 
The issue of time difference brings the validity of this finding into question – if maternal 
tachycardia has been present – could there have been a possible underlying infection, and 
if not, what was the reason for the tachycardia at the time? Further hypothesis testing was 
requested from the statistician to calculate whether there is a significant difference 
between infections in the case group versus the control group. A test for equality of 
proportions was done between the two groups that confirmed a p-value of 0.07 thus 
showing no significant difference between the groups of infection. 
The incidence of maternal mortality was overall 1% in each group (n=1 case and n=1 
control group). The cause of death for both participants was related to HIV. It is 
indeterminate to speculate that the population size will affect the increase in mortality 
incidence, as the numbers are very small. 
The mean birth weight for the case group (3226g) exceeded the mean birth weight for the 
control group (3032g). The significant difference in mean birth weight indicates that the 
case group’s neonates generally weighed more. The fact that the gestational age did not 
differ significantly between the two groups, further supports the significance of the higher 
birth weight in the case group. There were no significant differences in the Apgar scores 
between the two groups. 
The total neonatal morbidity in the case group accounted for 7.4% (n=7) and in the control 
group for 10% (n=10). These numbers indicates a higher prevalence of neonatal 
complications in the control group. There were two neonatal deaths in the control group 
and one in the case group. The neonatal death in the case group was due to transposition 
of the great arteries. One neonatal death in the control group was related to intrauterine 
growth restriction as caused by utero-placental insufficiency. The cause of the other infant 
death in the control group has not yet been classified. There were no intra-uterine deaths 
in either group. As the numbers were very small, once again, it would be premature to 
state that the difference between the two groups was significant or not.  
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After careful consideration of all the results mentioned above, the hypothesis that 
“maternal tachycardia in late pregnancy is associated with adverse maternal and perinatal 
outcomes” could not be accepted. Therefore this hypothesis was rejected. 
Table 5.2: Summary of maternal morbidity in the two groups 
 
Groups 
30. Maternal 
morbidity 
Healthy 
30. Maternal 
morbidity 
Infection 
30. Maternal 
morbidity 
Anaemia 
30. Maternal 
morbidity 
Other 
haematologic
al conditions 
30. Maternal 
morbidity 
Other 
 
Total 
Case 50 (54.0%) 17 (18.0%) 9 (10.0%) 3 (3.0%) 14 (15.0%) 93 
Control 66 (67.0%) 9 (9.0%) 8 (8.0%) 3 (3.0%) 12 (12.0%) 98 
5.3 LIMITATIONS OF THE STUDY 
5.3.1 Lack of recording of vital signs, clinical findings and observations 
The written information that was collected from the hospital notes and maternity case 
record booklets was habitually incomplete. This limited the actual data that was collected 
for this study. For example, the data of 51 participants of the Hb-value at 34 to 38 weeks 
was not available. However, as the differences in the mean Hb-values in this period was 
very small and did not differ significantly, it is unlikely that more available information 
would have changed the findings.  
5.3.2 Lack of time 
The limited time is believed to have been a shortfall in this study; therefore another study 
planned within a longer timeframe would be beneficial to collect more comprehensive data 
from a larger sample size in order to substantiate the study findings. Expanding the 
sample size means a far more accurate yield of statistics on women with cardiac disease.  
5.4 RECOMMENDATIONS 
5.4.1 Further research 
On the basis of the above-mentioned limitation, this study should be seen as an 
introduction to a more extensive study in this field. Hence, further research is needed in 
this area of study. With the implementation of the new maternity case record booklet, it is 
important to evaluate the effectiveness it has on patient health. 
5.4.2 Proper assessment of the respiratory and cardiovascular systems 
Emphasis should be put on the importance of a complete physical examination of the 
maternal heart. Professional nurses and midwives doing the first encounter visit with a 
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pregnant woman must be competent enough to examine the respiratory and 
cardiovascular systems to be able to detect any abnormalities that exist or are arising. 
None of the researcher’s data reflects how well the examination of the maternal heart at 
the first antenatal visit was done and recorded. However, during the process of data 
collection, the researcher often noticed incomplete entries at the space on the maternity 
case record booklet where the entry of the examination of the heart should be entered. 
This places an uncertainty with the researcher to whether a proper examination of the 
heart and respiratory systems has been done in practice.    
5.4.3 Generalising study findings 
For future research in this field of study, a larger population and sample size can be 
selected in order to be able to generalise the findings of the study. 
5.5 FINAL CONCLUSION  
One of the outcomes of this study revealed that no pre-existing cardiac conditions were 
diagnosed in the population attending a government clinic in the Western Cape. Hence, 
this confirms that it is not necessary to record the maternal heart rate during every 
antenatal visit. Although the results from this study have highlighted a higher prevalence of 
infection in patients presenting with maternal tachycardia in late pregnancy, this difference 
was not significant between the two groups.  
Even though there was no prevalence of cardiac disease and/or complications in this 
study, the researcher determined the prevalence of maternal tachycardia in a 
subpopulation of a study conducted in the Western Cape. To the researcher’s knowledge, 
this is the first study known to examine the prevalence of maternal tachycardia in late 
pregnancy and the first to demonstrate that maternal tachycardia is associated with better 
fetal growth in uncomplicated cases. 
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VARIABLE Nr PASS 
Pat ID 
GROUP Maternal age Race Gravidity Parity Pregnancy losses 
DESCRIPTION   Case Control 
 
 B Black 
C Coloured 
W White 
O Other 
 
1 
2 
3 
4 
5 
6 and more 
 
0 
1 
2 
3 
4 
5 and more 
 
AB1 Abortion 1 
AB2 Abortion 2 
MISC Miscarriage 1 
MISC Miscarriage 2 
NND Neonatal death 
ID Infant death 
IUD Intra-uterine 
death 
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6. Height 7. Weight 8. MHR Maternal 9. MHR Basal fetal 10. MHR 
Success rate 
11. MHR 
Duration of 
recording 
12. MHR 
Date of 
recording 
13. Time 
last smoked 
14. Time 
MHR 
recorded 
  C Continuous 
C100 Continuous 
(>100bpm all 
the time) 
TB Tachycardia at 
beginning, 
normal heart 
rate at end 
TE Tachycardia at 
end, normal 
heart rate at 
beginning 
F100 Fluctuations to 
> 100bpm 
F Fluctuations 
O Other 
 
C Continuous 
C160 Continuous (> 160 bpm all 
the time) 
TB Tachycardia at beginning, 
normal heart rate at end 
TE Tachycardia at end, 
normal heart rate at 
beginning 
F160 Fluctuations at above 160 
bpm 
F Fluctuations 
O Other  
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15. 
Number of 
ANC visits 
16. Frequency of 
MHR recordings 
17. MHRRA Booking 18. 
MHRRA 
Other 
ANC 
visits 
19. MHRRA 
Walk-in 
visits 
20. MHRRA 
Referrals 
21. MHRRA Labour 22. MHRRA Post-
delivery 
23. Hb 
booking 
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24. Hb 
28-38 
weeks 
25. Hb 
delivery 
26. Hb 
frequency 
27. Facility of delivery 28. Mode of delivery 29. Pre-existing conditions 30. Maternal morbidity 31. Maternal 
mortality 
   MOU 
KBH 
TBH 
Other 
 
N NVD 
C C/Section 
S Suction 
F Forceps 
VB Vaginal breech 
delivery 
 
CA Coronary 
artery 
disease 
MI Myocardial 
infarction 
C Cardiomyop
athy 
VHD Valvular 
heart 
disease 
CHD Congenital 
heart 
disease 
O Other 
H Healthy 
 
A Anaemia 
CD Cardiac disease 
CC Cardiac 
complications 
I Infection 
HC Haematological 
cnditions 
O Other 
H Healthy 
 
Y Yes 
N No 
 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
Stellenbosch University  http://scholar.sun.ac.za
123 
 
 
32. Neonatal 
gender 
33. Neonatal morbidity 34. Neonatal 
mortality 
35. 
Birth 
weight 
36. GA at 
delivery 
days 
37. GA at 
delivery 
weeks 
38. SGA 39. Apgar 1 min 40. Apgar 5 
min 
41. Apgar 
10 min 
F Female 
M Male 
 
RDS Respiratory distress 
syndrome 
I Infection 
NJ Neonatal jaundice 
O Other 
H Healthy 
 
A Alive 
M Miscarriage 
I IUD 
N NND 
ID Infant death 
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